welldevelop
anim
model
necessari
understand
diseas
progress
pathogenesi
immunolog
respons
viral
infect
human
furthermor
test
vaccin
medic
countermeasur
anim
model
essenti
preclin
studi
ideal
anim
model
human
viral
infect
mimic
hostpathogen
interact
diseas
progress
seen
natur
diseas
cours
good
anim
model
viral
infect
allow
assay
mani
paramet
infect
includ
clinic
sign
growth
viru
clinicopatholog
paramet
cellular
humor
immun
respons
virushost
interact
furthermor
viral
replic
accompani
measur
clinic
manifest
patholog
resembl
human
case
better
understand
diseas
process
human
attain
often
one
anim
model
close
repres
human
diseas
given
pathogen
small
anim
model
typic
use
firstlin
screen
test
efficaci
vaccin
therapeut
contrast
nonhuman
primat
nhp
model
often
use
pivot
preclin
studi
approach
also
use
basic
pathogenesi
studi
studi
small
anim
model
possibl
studi
nhp
fill
remain
gap
knowledg
advantag
use
mice
develop
anim
model
low
cost
low
genet
variabl
inbr
strain
abund
molecular
biolog
immunolog
reagent
specif
pathogen
free
spf
transgen
knockout
mice
also
avail
major
pitfal
mous
model
pathogenesi
protect
afford
vaccin
therapeut
alway
extrapol
human
addit
blood
volum
sampl
limit
small
anim
virus
often
need
adapt
serial
passag
speci
induc
product
infect
ferret
airway
anatom
histolog
similar
human
size
enabl
collect
larger
frequent
blood
sampl
make
ideal
model
certain
respiratori
pathogen
ferret
outbr
standard
breed
strain
thu
greater
number
requir
studi
achiev
statist
signific
overcom
result
variabl
respons
addit
spf
transgen
ferret
avail
molecular
biolog
reagent
lack
caveat
make
ferret
model
difficult
work
requir
space
mice
rabbitstyl
cage
develop
aggress
behavior
repeat
procedur
nhp
genet
closest
speci
human
thu
diseas
progress
hostpathogen
respons
viral
infect
often
similar
human
howev
ethic
concern
pertain
experiment
nhp
along
high
cost
lack
spf
nhp
rais
barrier
studi
nhp
studi
care
design
ensur
fewest
number
anim
use
studi
address
critic
question
regard
diseas
pathogenesi
hostpathogen
respons
protect
efficaci
vaccin
therapeut
welldesign
experi
care
evalu
choic
anim
includ
strain
sex
age
furthermor
depend
pathogen
rout
exposur
dose
mimic
rout
exposur
dose
human
diseas
endpoint
studi
also
import
criterion
depend
desir
outcom
model
system
emul
host
respons
human
infect
pathogen
summari
small
anim
model
help
initi
screen
vaccin
therapeut
often
benefici
obtain
basic
understand
diseas
nhp
model
use
detail
character
pathogenesi
pivot
preclin
test
studi
ultim
ideal
anim
model
may
avail
case
combin
differ
wellcharacter
anim
model
consid
understand
diseas
progress
test
medic
countermeasur
diseas
chapter
review
anim
model
repres
member
numer
viru
famili
caus
human
diseas
focu
virus
famili
greatest
concern
public
health
worldwid
noroviru
genu
norwalk
prototyp
member
common
caus
gastroenter
unit
state
hall
et
al
five
distinct
genogroup
gigv
numer
strain
norwalk
viru
includ
particularli
signific
human
pathogen
norwalk
viru
snow
mountain
viru
hawaii
viru
develop
countri
norwalk
viru
also
known
winter
vomit
viru
respons
approxim
death
annual
patel
et
al
typic
diseas
cours
selflimit
incid
necrot
enterocol
seizur
infant
chen
et
al
lutgehetmann
et
al
turciosruiz
et
al
symptom
infect
includ
diarrhea
vomit
nausea
abdomin
cramp
dehydr
fever
incub
normal
day
symptom
persist
day
koopman
duizer
viral
shed
rang
day
healthi
individu
atmar
et
al
howev
longer
ill
durat
indic
immunocompromis
statu
elderli
young
prolong
state
shed
harri
et
al
rockx
et
al
interestingli
individu
vari
greatli
suscept
noroviru
infect
depend
fucosyl
transferas
allel
function
histoblood
group
antigen
statu
type
individu
suscept
type
ab
b
resist
hutson
et
al
transmiss
occur
predomin
oralfec
rout
contamin
food
water
major
vector
atmar
est
becker
et
al
koopman
duizer
vomit
result
airborn
dissemin
viru
area
contamin
subsequ
transmiss
oral
deposit
airborn
particl
contact
contamin
fomit
remain
contamin
day
makison
booth
tungthompson
et
al
vomit
event
classroom
set
elev
risk
noroviru
ill
among
elementari
student
proxim
correl
attack
rate
evan
et
al
mark
et
al
viral
titer
emesi
fecal
suspens
high
ge
genom
equival
copi
per
millilit
respect
infecti
dose
ge
atmar
et
al
therefor
outbreak
extrem
difficult
contain
therapeut
intervent
consist
rehydr
therapi
antiemet
medic
bucardo
et
al
moe
et
al
approv
vaccin
therapeut
avail
develop
challeng
given
immun
shortliv
infect
new
strain
rapidli
evolv
correl
protect
complet
understood
chen
et
al
howev
one
promis
strategi
util
viruslik
particl
vlp
base
vaccin
protect
reduc
infect
almost
human
volunt
aliabadi
et
al
atmar
et
al
given
rel
benign
diseas
adult
experiment
challeng
carri
human
volunt
ball
et
al
tacket
et
al
viral
titer
determin
shed
fece
sera
histopatholog
chang
monitor
biopsi
particularli
duodenum
ph
emesi
sampl
collect
contain
viru
consist
viral
replic
small
intestin
reflux
stomach
kirbi
et
al
addit
norwalk
viru
shown
bind
duoden
tissu
chan
et
al
howev
type
research
technic
difficult
expens
thu
model
develop
major
hindranc
basic
research
pathogen
lack
permiss
cell
cultur
system
anim
model
norwalk
viru
nhp
includ
marmoset
cottontop
tamarin
rhesu
macaqu
infect
norwalk
viru
monitor
extent
viral
shed
howev
clinic
diseas
observ
model
diseas
progress
sever
measur
exclus
assay
viral
shed
rockx
et
al
incident
virus
need
creat
infect
challeng
oral
rout
intraven
iv
rout
purcel
et
al
chimpanze
expos
clinic
isol
norwalk
viru
iv
rout
bok
et
al
although
none
anim
develop
diseas
symptom
viral
shed
within
fece
observ
within
day
postinfect
last
anywher
day
week
viremia
never
occur
histopatholog
chang
detect
amount
durat
viral
shed
inlin
observ
upon
human
infect
chimer
chimpanzeehuman
antinoroviru
neutral
antibodi
explor
possibl
therapeut
strategi
chen
et
al
recent
identifi
caliciviru
rhesu
origin
name
tulan
viru
use
surrog
model
infect
unlik
norwalk
viru
tulan
viru
cultur
cell
rhesu
macaqu
expos
tulan
viru
intragastr
develop
diarrhea
fever
day
postinfect
viral
shed
detect
day
immun
system
produc
antibodi
drop
concentr
within
day
postinfect
mirror
shortliv
immun
document
human
intestin
develop
moder
blunt
villi
seen
human
diseas
sestak
et
al
murin
noroviru
identifi
close
relat
human
norwalk
viru
karst
et
al
howev
clinic
viru
present
differ
diseas
murin
noroviru
model
includ
observ
gastrointestin
clinic
sign
possibl
part
rodent
lack
vomit
reflex
addit
mice
infect
noroviru
develop
persist
infect
contrast
human
diseas
hsu
et
al
hsu
et
al
khan
et
al
porcin
enter
calicivirus
induc
diarrheal
diseas
young
pig
asymptomat
infect
adult
wang
et
al
gnotobiot
pig
success
infect
passag
clinic
noroviru
isol
oral
rout
diarrheal
diseas
develop
anim
viru
detect
stool
anim
major
histopatholog
chang
viral
persist
note
cheetham
et
al
calv
natur
infect
bovin
norovirus
scipioni
et
al
experiment
challeng
calv
oral
inocul
bovin
isol
result
diarrheal
diseas
h
postinfect
recoveri
viru
achiev
h
postinfect
otto
et
al
eastern
equin
enceph
viru
eeev
western
equin
enceph
viru
weev
venezuelan
equin
enceph
viru
veev
present
near
synonym
symptom
major
human
case
asymptomat
present
flulik
ill
progress
central
nervou
system
cn
involv
includ
seizur
paralysi
mortal
rate
vari
among
viru
highest
report
eev
follow
weev
lastli
veev
less
ayer
et
al
griffin
steel
twenhafel
current
licens
vaccin
therapi
recent
phase
clinic
trial
veev
dna
vaccin
result
veevneutr
antibodi
respons
subject
hannaman
et
al
mous
model
develop
numer
rout
infect
includ
cutan
intranas
intracrani
ic
aerosol
eeev
suscept
mous
model
correl
age
younger
mice
suscept
adult
importantli
eeev
pathogenesi
depend
rout
infect
delay
progress
upon
subcutan
subq
exposur
honnold
et
al
newborn
mice
display
neuron
damag
rapid
diseas
progress
result
death
murphi
whitfield
similarli
eeev
produc
fatal
enceph
older
mice
administ
via
intracerebr
rout
inocul
via
subq
rout
caus
pantrop
infect
eventu
result
enceph
liu
et
al
morgan
gener
drawback
usag
mous
model
lack
vascular
involv
diseas
cours
liu
et
al
subq
inocul
weev
suckl
mice
start
show
sign
diseas
h
die
within
h
aguilar
heart
organ
patholog
chang
observ
convers
adult
mice
exhibit
sign
lethargi
ruffl
fur
day
postinfect
mice
sever
ill
day
appear
hunch
dehydr
death
occur
day
brain
mesoderm
tissu
heart
lung
liver
kidney
involv
aguilar
monath
et
al
intracerebr
rout
infect
result
fatal
diseas
highli
depend
dose
intraderm
id
subq
inocul
caus
fatal
mice
regardless
amount
viru
liu
et
al
compar
suscept
inbr
outbr
strain
reveal
balbc
aj
mice
highli
suscept
experiment
infect
via
subq
inocul
challeng
prior
week
old
cn
involv
lethal
blake
et
al
subqderm
infect
mous
model
result
encephalit
diseas
similar
seen
hors
human
macdonald
johnston
viru
begin
replic
drain
lymph
node
h
postinocul
eventu
viru
enter
brain
primarili
via
olfactori
system
furthermor
aerosol
exposur
mice
veev
result
massiv
infect
olfactori
neuroepithelium
olfactori
nerv
olfactori
bulb
viral
spread
brain
result
necrot
panenceph
charl
et
al
steel
et
al
aerosol
dermal
inocul
rout
caus
neurolog
patholog
mice
much
faster
rout
exposur
clinic
sign
diseas
mice
infect
aerosol
ruffl
fur
lethargi
hunch
progress
death
charl
et
al
steel
twenhafel
steel
et
al
challeng
mice
high
dose
veev
caus
high
morbid
mortal
juland
et
al
viral
titer
brain
peak
day
postchalleng
remain
elev
anim
succumb
day
postchalleng
protein
cytokin
array
perform
brain
infect
mice
show
elev
rant
level
model
use
success
test
antivir
veev
juland
et
al
addit
veev
vaccin
inactiv
azid
protect
footpad
aerosol
challeng
virul
veev
mous
model
gupta
et
al
guinea
pig
hamster
also
develop
anim
model
eeev
studi
paessler
et
al
roy
et
al
guinea
pig
develop
neurolog
involv
decreas
activ
tremor
circl
behavior
coma
neuron
necrosi
observ
brain
lesion
experiment
challeng
anim
roy
et
al
subq
inocul
eeev
produc
lethal
biphas
diseas
hamster
sever
lesion
nerv
cell
earli
viscer
phase
viremia
follow
neuroinvas
enceph
death
addit
parenchyma
necrosi
observ
liver
lymphoid
organ
paessler
et
al
harlan
spraguedawley
hamster
develop
viremia
progress
respiratori
gastrointestin
nervou
system
involv
inocul
via
subq
rout
vascul
enceph
evid
model
mirror
human
diseas
clinic
spectrum
paessler
et
al
weev
highli
infecti
guinea
pig
util
prophylact
screen
sidwel
smee
studi
demonstr
although
length
incub
period
diseas
durat
vari
weev
infect
result
mortal
hamster
rout
inocul
progress
lack
coordin
shiver
rapid
noisi
breath
corneal
opac
conjunctiv
discharg
result
close
eyelid
indic
diseas
case
zlotnik
et
al
cn
involv
evid
intracerebr
intraperiton
ip
id
inocul
zlotnik
et
al
ip
inocul
weev
fatal
guinea
pig
regardless
amount
viru
inoculum
anim
exhibit
sign
ill
day
follow
death
day
nalca
unpublish
result
id
im
iv
inocul
eeev
nhp
caus
diseas
reliabl
result
neurolog
symptom
dupuy
reed
intracerebr
infect
eeev
produc
nervou
system
diseas
fatal
monkey
nathanson
et
al
differ
model
indic
initi
viremia
secondari
nervou
system
infect
overlap
nhp
inocul
peripher
rout
wyckoff
intralingu
inocul
eeev
also
caus
nervou
system
symptom
monkey
less
drastic
intracerebr
inject
wyckoff
aerosol
rout
deliveri
result
uniformli
lethal
diseas
cynomolgu
macaqu
reed
et
al
model
fever
follow
elev
white
blood
cell
liver
enzym
neurolog
sign
subsequ
develop
nhp
becam
moribund
euthan
day
postexposur
meningoencephalomyel
main
patholog
observ
brain
anim
steel
twenhafel
similar
clinic
sign
patholog
observ
common
marmoset
infect
eeev
rout
adam
et
al
aerosol
nhp
model
similar
diseas
progress
patholog
seen
human
diseas
limit
studi
perform
nhp
reed
et
al
expos
cynomolgu
macaqu
low
high
dose
aerosol
weev
anim
subsequ
develop
fever
increas
white
blood
count
cn
involv
demonstr
cynomolgu
macaqu
model
could
use
test
vaccin
therapeut
weev
reed
et
al
veev
infect
caus
typic
biphas
febril
respons
nhp
initi
fever
observ
h
infect
last
less
h
secondari
fever
gener
began
day
last
day
gleiser
et
al
veevinfect
nhp
exhibit
mild
symptom
anorexia
irrit
diarrhea
tremor
leukopenia
common
anim
exhibit
fever
monath
et
al
support
leukopenia
microscop
chang
lymphat
tissu
earli
destruct
lymphocyt
lymph
node
spleen
mild
lymphocyt
infiltr
hepat
triad
focal
myocardi
necrosi
lymphocyt
infiltr
observ
monkey
infect
veev
surprisingli
characterist
lesion
cn
observ
histopatholog
monkey
spite
lack
clinic
sign
infect
gleiser
et
al
primari
lesion
lymphocyt
perivascular
cuf
glial
prolifer
gener
observ
day
postinfect
secondari
febril
episod
similar
observ
cynomolgu
macaqu
expos
aerosol
veev
fever
viremia
lymphopenia
clinic
sign
enceph
observ
nhp
succumb
diseas
reed
et
al
common
marmoset
model
util
comparison
studi
south
america
sa
north
america
na
strain
eeev
adam
et
al
previou
studi
indic
sa
strain
less
virul
na
strain
human
common
marmoset
infect
either
na
sa
strain
eeev
na
straininfect
anim
show
sign
anorexia
neurolog
involv
euthan
day
challeng
although
sa
straininfect
anim
develop
viremia
remain
asymptomat
surviv
end
studi
chikungunya
viru
chikv
member
genu
alphavirus
specif
semliki
forest
complex
respons
multitud
epidem
center
within
africa
southeast
asia
griffin
viru
transmit
aed
aegypti
aed
albopictu
mosquito
given
widespread
endem
aed
mosquito
chikv
potenti
spread
previous
unaffect
area
typifi
emerg
diseas
report
first
time
island
southwest
indian
ocean
includ
french
la
reunion
island
appear
central
itali
charrel
et
al
rezza
et
al
incub
period
follow
mosquito
bite
day
lead
selflimit
acut
phase
last
day
symptom
period
includ
fever
arthralgia
myalgia
rash
headach
weak
nausea
vomit
polyarthralgia
report
power
logu
individu
typic
develop
stoop
postur
due
pain
approxim
infect
individu
joint
pain
last
month
resolut
primari
diseas
possibl
relaps
underli
health
condit
includ
diabet
alcohol
renal
diseas
increas
risk
develop
sever
form
diseas
includ
hepat
encephalopathi
children
age
year
old
increas
risk
develop
neurolog
manifest
arpino
et
al
current
approv
vaccin
antivir
wildtyp
adult
mice
permiss
chikv
infect
id
inocul
howev
demonstr
neonat
mice
suscept
sever
depend
upon
age
infect
sixdayold
mice
develop
paralysi
day
succumb
day
wherea
mice
abl
recov
infect
day
mice
longer
permiss
diseas
symptomat
mice
develop
loss
balanc
hind
limb
drag
skin
lesion
neonat
mice
also
use
model
neurolog
complic
couderc
et
al
ziegler
et
al
adult
mous
model
develop
inject
ventral
side
footpad
mice
viremia
last
day
accompani
foot
swell
note
inflamm
musculoskelet
tissu
morrison
et
al
adult
knockout
mice
also
develop
mild
diseas
symptom
includ
muscl
weak
lethargi
symptom
mirror
human
infect
adult
mice
die
within
day
model
use
identifi
viral
cellular
tropism
fibroblast
couderc
et
al
icr
mice
also
util
diseas
model
neonat
mice
inocul
subq
passag
clinic
isol
chikv
develop
lethargi
loss
balanc
difficulti
walk
mortal
low
newborn
icr
mice
respect
remain
mice
fulli
recov
within
week
infect
ziegler
et
al
drawback
mice
diseas
result
immunopathogenesi
occur
human
case
given
mice
immunocompromis
teo
et
al
chronic
infect
model
develop
use
recombin
activ
gene
knockout
mice
studi
mice
inocul
via
footpad
lost
weight
comparison
control
group
footpad
subq
inject
mice
develop
viremia
day
postinfect
detect
day
postinfect
inflamm
evid
brain
liver
lung
subq
inocul
anim
day
postinfect
despit
minim
footpad
swell
day
postinfect
day
sever
muscl
damag
note
necropsi
resolv
day
seymour
et
al
golden
hamster
serv
anoth
option
small
anim
model
although
hamster
appear
develop
overt
clinic
symptom
follow
subq
inocul
viremia
develop
major
anim
within
day
postinfect
clearanc
follow
day
histolog
inflamm
note
skelet
muscl
fascia
tendon
sheath
numer
limb
studi
limit
number
anim
util
work
need
develop
hamster
model
boscolauth
et
al
nhp
model
diseas
includ
adult
age
pregnant
rhesu
macaqu
addit
cynomolgu
macaqu
broeckel
et
al
differ
rout
infect
subq
iv
im
success
administ
although
clear
understand
role
rout
transmiss
play
subsequ
pathogenesi
clinic
symptom
typic
viremia
observ
day
postinfect
correl
infecti
titer
time
viremia
observ
cynomolgu
rhesu
labadi
et
al
messaoudi
et
al
fever
began
day
postinfect
persist
day
day
cynomolgu
rhesu
respect
coincid
rash
chen
et
al
labadi
et
al
messaoudi
et
al
overal
blood
chemistri
chang
conjunct
initi
viremia
return
baselin
day
postexposur
chen
et
al
cn
involv
difficult
reproduc
nhp
model
although
report
high
inoculum
cynomolgu
result
meningoenceph
labadi
et
al
nhp
model
util
conduct
efficaci
test
novel
vaccin
therapeut
broeckel
et
al
dengu
viru
denv
transmit
via
mosquito
vector
aegypti
albopictu
moor
mitchel
given
endem
vector
estim
half
world
popul
risk
exposur
denv
result
approxim
million
case
dengu
year
burden
diseas
tropic
subtrop
region
latin
america
south
asia
southeast
asia
gubler
estim
death
year
due
dengu
hemorrhag
fever
dhf
guzman
kouri
four
distinct
serotyp
denv
number
capabl
caus
wide
clinic
spectrum
rang
asymptomat
sever
develop
dhf
world
health
organ
incub
rang
day
averag
day
viru
target
dendrit
cell
macrophag
follow
mosquito
bite
balsiti
et
al
typic
infect
result
classic
dengu
fever
df
selflimit
flulik
symptom
conjunct
retroorbit
pain
headach
skin
rash
bone
muscl
pain
dhf
follow
vascular
leak
syndrom
low
platelet
count
result
hemorrhag
extrem
case
dengu
shock
syndrom
dss
develop
character
hypotens
shock
circulatori
failur
world
health
organ
thrombocytopenia
hallmark
clinic
sign
infect
aid
differenti
diagnosi
gregori
et
al
sever
diseas
higher
propens
occur
upon
secondari
infect
differ
denv
serotyp
thein
et
al
hypothes
occur
due
antibodi
depend
enhanc
ade
approv
vaccin
drug
hospit
patient
receiv
support
care
includ
fluid
replac
order
progress
toward
effect
drug
vaccin
small
human
cohort
studi
taken
place
howev
provid
statist
relev
result
test
must
progress
anim
model
develop
anim
model
import
note
mosquito
typic
deposit
pfu
consid
optim
rang
experiment
challeng
denv
natur
replic
effect
rodent
cell
creat
need
mouseadapt
strain
engin
mous
line
varieti
inocul
rout
overcom
initi
barrier
sever
laboratori
mous
strain
includ
aj
balbc
permiss
dengu
infect
howev
result
diseas
littl
resembl
human
clinic
sign
death
result
paralysi
huang
et
al
pae
et
al
shresta
et
al
higher
dose
adapt
denv
strain
induc
dhf
symptom
balbc
souza
et
al
model
also
yield
asymptomat
infect
mouseadapt
strain
denv
introduc
mice
develop
vascular
leak
syndrom
similar
sever
diseas
seen
human
shresta
et
al
passiv
transfer
monoclon
dengu
antibodi
within
mice
lead
ade
cours
infect
viremia
increas
anim
die
due
vascular
leak
syndrom
balsiti
et
al
anoth
mouseadapt
strain
inject
balbc
caus
liver
damag
hemorrhag
manifest
vascular
permeabl
souza
et
al
ic
inject
suckl
mice
denv
lead
death
paralysi
enceph
rare
human
infect
lee
et
al
parida
et
al
zhao
et
al
immunocompromis
mice
also
use
gain
understand
pathogenesi
denv
welldefin
model
defici
receptor
recapitul
dhfdss
mouseadapt
strain
util
yauch
et
al
scid
mice
engraft
human
tumor
cell
develop
paralysi
upon
infect
thu
use
pathogenesi
studi
blaney
et
al
lin
et
al
df
symptom
develop
infect
mice
engraft
human
progenitor
cell
mota
ricohess
raghu
mice
develop
fever
symptom
upon
infect
passag
clinic
isol
labadapt
strain
denv
kuruvilla
et
al
passag
clinic
isol
denv
use
creat
model
immunocompet
adult
mice
ip
inject
balbc
caus
lethal
day
postinfect
dose
depend
manner
first
indic
infect
weight
loss
begin
day
follow
thrombocytopenia
drop
systol
blood
pressur
along
note
increas
liver
enzym
ast
alt
also
observ
viremia
establish
day
model
mimick
characterist
symptom
observ
human
dhfdss
case
costa
et
al
vascular
leakag
also
observ
inocul
denv
st
john
et
al
murin
model
develop
util
infect
mosquito
rout
transmiss
hunsg
mice
femal
mosquito
intrathorac
inocul
clinic
isol
denv
infect
mosquito
fed
upon
mous
footpad
allow
transmiss
viru
via
natur
rout
amount
viru
detect
within
mous
directli
proport
number
mosquito
expos
optim
detect
viral
rna
line
histor
human
infect
data
sever
thrombocytopenia
develop
day
model
notabl
diseas
enhanc
mosquito
deliveri
viru
comparison
inject
viru
cox
et
al
nhp
model
use
subq
inocul
attempt
induc
diseas
although
anim
permiss
viral
replic
lower
degre
observ
human
infect
marchett
et
al
immunosuppress
drug
cyclophosphamid
enhanc
infect
rhesu
macaqu
allow
viru
invad
monocyt
marchett
et
al
throughout
preliminari
studi
clinic
diseas
detect
order
circumv
higher
dose
denv
use
iv
challeng
rhesu
macaqu
hemorrhag
manifest
appear
day
result
petechia
hematoma
coagulopathi
howev
symptom
develop
onlamoon
et
al
robust
antibodi
respons
observ
multipl
studi
marchett
et
al
onlamoon
et
al
marmoset
also
mirror
human
dengu
infect
develop
fever
leukopenia
thrombocytopenia
follow
subq
inocul
omatsu
et
al
omatsu
et
al
nhp
abl
produc
antibodi
similar
observ
cours
human
infect
make
advantag
studi
ade
sequenti
infect
led
crossreact
antibodi
respons
demonstr
human
mice
midgley
et
al
phenotyp
also
seen
upon
passiv
transfer
monoclon
antibodi
dengu
subsequ
infect
viru
rhesu
macaqu
expos
manner
develop
viremia
higher
previous
report
howev
clinic
sign
appar
goncalvez
et
al
lack
induc
dhf
dss
symptom
hinder
examin
pathogenesi
within
model
west
nile
viru
wnv
first
isol
blood
woman
west
nile
district
uganda
uganda
smithburn
et
al
initi
isol
wnv
viru
subsequ
isol
patient
bird
mosquito
egypt
earli
melnick
et
al
taylor
et
al
shown
caus
enceph
human
hors
wnv
recogn
widespread
flavivirus
geograph
distribut
includ
africa
middl
east
western
asia
europ
australia
hay
viru
first
reach
western
hemispher
summer
outbreak
involv
human
hors
bird
new
york
citi
metropolitan
area
center
diseas
control
prevent
lanciotti
et
al
sinc
rang
area
affect
wnv
quickli
extend
older
peopl
children
suscept
wnv
diseas
wnv
gener
caus
asymptomat
diseas
mild
undifferenti
fever
west
nile
fever
last
day
monath
tsai
mortal
rate
follow
neuroinvas
diseas
rang
asni
et
al
hay
hubalek
halouzka
komar
sever
complic
commonli
seen
elderli
report
case
fatal
rate
hepat
myocard
pancreat
unusu
sever
nonneurolog
manifest
wnv
infect
inocul
wnv
nhp
intracerebr
result
develop
either
enceph
febril
diseas
asymptomat
infect
depend
viru
strain
dose
viral
persist
observ
anim
regardless
outcom
infect
ie
asymptomat
fever
enceph
pogodina
et
al
thu
viral
persist
regard
typic
result
nhp
infect
variou
wnv
strain
intracerebr
subq
inocul
viru
local
predominantli
brain
may
also
found
kidney
spleen
lymph
node
wnv
result
clinic
diseas
nhp
although
anim
show
low
level
viremia
lieberman
et
al
pletnev
et
al
mirror
new
zealand
white
rabbit
develop
fever
low
level
viremia
follow
inocul
via
footpad
suen
et
al
id
inocul
marmoset
rhesu
macaqu
yield
clinic
sign
diseas
includ
fever
viremia
detect
nhp
speci
marmoset
develop
higher
titer
greater
durat
rhesu
verstrepen
et
al
wnv
also
extens
studi
small
anim
classic
laboratori
mous
strain
suscept
lethal
infect
intracerebr
ip
rout
result
enceph
mortal
id
rout
pathogenesi
studi
indic
langerhan
dendrit
cell
initi
viral
replic
site
skin
brown
et
al
johnston
et
al
infect
langerhan
cell
migrat
lymph
node
viru
enter
blood
lymphat
thorac
duct
dissemin
peripher
tissu
secondari
viral
replic
viru
eventu
travel
cn
caus
patholog
similar
human
case
byrn
et
al
cunha
et
al
diamond
et
al
fratkin
et
al
swiss
mous
strain
inocul
ip
order
screen
varieti
viral
lineag
assess
differ
pathogenesi
bingham
et
al
tesh
et
al
develop
model
wn
enceph
use
golden
hamster
mesocricetu
auratu
hamster
appear
asymptomat
first
day
becam
letharg
approxim
day
develop
neurolog
symptom
day
mani
sever
affect
anim
die
day
infect
viremia
detect
hamster
within
h
infect
persist
day
although
substanti
chang
intern
organ
progress
patholog
differ
seen
brain
spinal
cord
infect
anim
furthermor
similar
previous
mention
monkey
experi
pogodina
et
al
persist
wnv
infect
found
brain
hamster
zika
viru
recent
came
forefront
public
health
concern
outbreak
brazil
end
clinic
diseas
spectrum
highli
variabl
report
flulik
ill
accompani
rash
guillanbarr
syndrom
microcephali
newborn
ramo
da
silva
gao
date
correl
gestat
age
exposur
viru
occur
sever
microcephali
fulli
understood
brasil
et
al
howev
recent
studi
pregnant
women
columbia
found
infect
zika
viru
third
trimest
associ
obviou
structur
abnorm
fetu
pacheco
et
al
transmiss
viru
occur
via
bite
infect
aegypti
albopictu
ramo
da
silva
gao
report
rout
exposur
includ
sexual
transmiss
blood
transfus
cunha
et
al
dortenzio
et
al
hill
et
al
mccarthi
emerg
viru
approv
vaccin
therapi
diagnost
option
demonstr
util
wellcharacter
anim
model
develop
first
demonstr
experiment
infect
mosquito
could
use
transmit
viru
mice
nhp
boorman
porterfield
mice
suscept
nonadapt
zika
viru
infect
follow
subq
inocul
limb
mice
began
lose
weight
day
postinfect
met
euthanasia
criteria
day
microscop
lesion
within
brain
note
upon
necropsi
conjunct
viral
rna
detect
blood
brain
ovari
spleen
liver
infect
mice
wildtyp
mice
also
challeng
observ
clinic
diseas
howev
viral
rna
detect
day
postinfect
blood
ovari
spleen
remain
detect
level
ovari
spleen
day
dowal
et
al
footpad
inocul
viru
lead
fatal
diseas
mice
day
postinocul
signific
histopatholog
chang
brain
note
necropsi
aliota
et
al
mice
also
observ
develop
neurolog
diseas
day
postexposur
rossi
et
al
immunocompet
mice
resist
infect
via
subq
rout
rossi
et
al
recent
mous
model
identifi
verifi
vertic
transmiss
viru
pregnant
mice
inject
either
ip
utero
later
ventricl
fetal
brain
ip
inocul
induc
transient
viremia
pregnant
mice
day
viral
rna
detect
five
nine
placenta
day
postinfect
viru
abl
infect
radial
glia
cell
fetal
brain
lead
reduct
cortic
neural
progenitor
viral
exposur
via
cerebroventricular
space
later
ventricl
fetal
brain
exhibit
small
brain
size
day
postexposur
addit
cortic
thin
cugola
et
al
li
et
al
pregnant
mice
expos
viru
nonviabl
fetus
studi
wildtyp
mice
given
antiifnar
antibodi
prior
infect
result
detect
viru
fetal
head
mild
intrauterin
growth
restrict
miner
et
al
murin
studi
studi
pathogenesi
vertic
transmiss
result
neurolog
disord
conjunct
screen
novel
countermeasur
nhp
studi
current
ongo
anim
model
develop
numer
virus
coronaviru
cov
famili
exist
infect
wide
rang
anim
six
speci
identifi
infect
human
two
alpha
coronaviru
four
beta
coronavirues
hcovsar
merscov
first
detect
nasal
passag
human
common
cold
gaunt
et
al
first
isol
caus
upper
lower
respiratori
infect
vari
intens
continu
circul
among
human
van
der
hoek
et
al
first
isol
identifi
sporad
also
caus
respiratori
infect
lau
et
al
signific
portion
common
cold
infect
human
caus
coronavirus
two
human
coronavirus
sarscov
merscov
emerg
caus
great
deal
alarm
sinc
infect
result
nearli
fatal
respect
assiri
et
al
peiri
et
al
etiolog
agent
sever
acut
respiratori
syndrom
sar
sarscov
emerg
spread
throughout
countri
period
month
confirm
infect
death
robert
subbarao
world
health
organ
addit
case
commun
acquir
sarscov
infect
report
sinc
natur
reservoir
sarscov
horsesho
bat
palm
civet
intermedi
host
lau
et
al
main
mechan
transmiss
sarscov
droplet
spread
also
viabl
dri
form
surfac
day
detect
stool
suggest
mode
transmiss
also
possibl
pearson
et
al
rabenau
et
al
rota
et
al
sarscov
infect
case
fatal
major
case
peopl
age
peiri
et
al
wang
et
al
incub
period
day
clinic
sign
sar
includ
gener
malais
fever
chill
diarrhea
dyspnea
cough
drosten
et
al
sar
case
pneumonia
may
develop
progress
acut
respiratori
distress
syndrom
ard
fever
usual
dissip
within
week
coincid
induct
high
level
neutral
antibodi
tan
et
al
human
sarscov
replic
destroy
respiratori
epithelium
great
deal
pathogenesi
due
subsequ
immun
respons
chen
subbarao
perlman
dandekar
infiltr
persist
within
lung
diffus
alveolar
damag
dad
common
sequela
sarscov
infect
perlman
dandekar
viru
isol
secret
upper
airway
earli
later
stage
infect
well
tissu
cheng
et
al
sarscov
replic
mani
speci
includ
dog
cat
pig
mice
rat
ferret
fox
monkey
roper
rehm
model
captur
aspect
human
clinic
diseas
pyrexia
respiratori
sign
mortal
viral
replic
patholog
robert
et
al
gener
sarscov
diseas
cours
model
speci
much
milder
shorter
durat
human
viral
replic
variou
anim
model
may
occur
without
clinic
ill
andor
histopatholog
chang
bestcharacter
model
util
mice
hamster
ferret
nhp
mous
model
sarscov
typic
inocul
rout
light
anesthesia
robert
et
al
young
balbc
mice
expos
sarscov
viral
replic
detect
lung
nasal
turbin
peak
day
clearanc
day
postexposur
mcauliff
et
al
also
viral
replic
within
small
intestin
young
balbc
mice
howev
young
mice
clinic
sign
asid
reduc
weight
gain
littl
inflamm
within
lung
pneumon
sarscov
infect
also
yield
reduc
weight
gain
viral
k
viral
diseas
replic
lung
peak
day
clearanc
day
glass
et
al
contrast
balbc
mice
month
age
show
weight
loss
hunch
postur
dehydr
ruffl
fur
day
postexposur
bisht
et
al
interstiti
pneumon
alveolar
damag
death
also
occur
old
mice
resembl
agedepend
virul
observ
human
mice
mice
show
outcom
sarscov
infect
similar
observ
balbc
mice
lower
titer
less
prolong
diseas
age
mous
model
frequent
use
young
mice
difficult
obtain
larg
number
mice
older
year
tabl
number
immunocompromis
knockout
mous
model
sarscov
infect
also
develop
mice
infect
sarscov
rout
develop
bronchiol
peribronchiolar
inflammatori
infiltr
interstiti
inflamm
adjac
alveolar
septa
viral
replic
diseas
mice
resolv
day
postexposur
beig
mice
infect
sarscov
similar
outcom
infect
balbc
mice
regard
viral
replic
time
viral
clearanc
lack
clinic
sign
glass
et
al
ko
mice
infect
sarscov
sever
diseas
weight
loss
pneumon
interstiti
pneumonia
death
ko
mous
model
therefor
use
studi
pathogen
patholog
evalu
vaccin
angiotensin
convert
enzym
identifi
cellular
receptor
sarscov
affin
spike
protein
viru
jeffer
et
al
variat
sequenc
across
anim
speci
could
partial
explain
differ
infect
sever
li
et
al
sutton
subbarao
sinc
mice
particular
greater
number
sequenc
differ
transgen
mice
creat
express
human
mccray
et
al
netland
et
al
yang
et
al
unlik
murin
model
sarscov
mice
express
mortal
sever
correl
level
express
tseng
et
al
high
level
express
mice
develop
sever
lung
brain
infect
howev
cn
k
viral
diseas
infect
rare
observ
human
infect
sarscov
syrian
golden
hamster
strain
lvg
also
suscept
exposur
sarscov
administr
tcid
along
period
transient
viremia
sarscov
replic
nasal
turbin
lung
result
pneumon
robert
et
al
obviou
sign
diseas
exercis
wheel
use
monitor
decreas
nighttim
activ
limit
mortal
observ
dose
depend
could
genet
differ
anim
strain
inbr
robert
et
al
damag
observ
liver
spleen
despit
detect
viru
within
tissu
sever
studi
shown
intratrach
inocul
sarscov
anesthet
ferret
mustela
furo
result
lethargi
fever
sneez
nasal
discharg
skowronski
et
al
clinic
diseas
observ
sever
studi
exclud
one
perhap
due
characterist
inocul
viru
kobing
et
al
sarscov
detect
pharyng
swab
trachea
tracheobronchi
lymph
node
high
titer
within
lung
mortal
observ
around
day
postexposur
well
mild
alveolar
damag
lung
occasion
accompani
sever
patholog
within
lung
martina
et
al
ter
meulen
et
al
fever
overt
respiratori
sign
lung
damag
mortal
ferret
intratrach
model
sarscov
infect
perhap
similar
human
sar
albeit
shorter
time
cours
sarscov
infect
nhp
intrans
rout
gener
result
mild
infect
resolv
quickli
sarscov
infect
old
world
monkey
rhesu
macaqu
cynomolgu
macaqu
cyno
african
green
monkey
agm
studi
variabl
result
possibl
due
outbr
natur
group
studi
previou
exposur
relat
pathogen
clinic
ill
viral
load
consist
howev
replic
within
lung
dad
featur
infect
primat
speci
cyno
ill
other
rash
lethargi
respiratori
sign
patholog
martina
et
al
mcauliff
et
al
row
et
al
rhesu
littl
diseas
mild
find
upon
histopatholog
analysi
row
et
al
agm
infect
sarscov
overt
clinic
sign
dad
pneumon
document
mcauliff
et
al
viral
replic
detect
day
lung
agm
howev
infect
resolv
progress
fatal
ard
farm
chines
mask
palm
civet
sold
open
market
china
involv
sarscov
outbreak
inocul
civet
sarscov
result
lethargi
decreas
aggress
fever
diarrhea
conjunct
leucopenia
pneumon
alveolar
septal
enlarg
lesion
similar
observ
ferret
nhp
also
observ
laboratoryinfect
civet
squirrel
monkey
mustach
tamarind
common
marmoset
suscept
sarscov
infect
greenough
et
al
robert
et
al
vaccin
develop
relat
anim
cov
chicken
cattl
dog
cat
swine
includ
liveattenu
kill
dna
viralvector
vaccin
strategi
cavanagh
import
issu
highlight
work
vaccin
cov
vaccin
develop
cat
may
induc
sever
diseas
perlman
dandekar
weiss
scott
immun
mice
immunopatholog
upon
sarscov
challeng
tseng
et
al
sever
hepat
vaccin
ferret
antibodi
enhanc
liver
report
weingartl
et
al
addit
rechalleng
agm
show
limit
viral
replic
signific
lung
inflamm
includ
alveol
interstiti
pneumonia
persist
long
period
time
viral
clearanc
clay
et
al
mous
nhp
model
increas
virul
may
develop
adapt
viru
repeat
passag
within
speci
interest
mouseadapt
sar
uniform
lethal
develop
serial
passag
lung
young
balbc
mice
mccray
et
al
robert
et
al
rockx
et
al
middl
east
respiratori
syndrom
merscov
emerg
saudi
arabia
associ
fever
sever
lower
respiratori
tract
infect
oftentim
renal
failur
altawfiq
et
al
omrani
et
al
mer
patient
also
occasion
manifest
neurolog
symptom
merscov
infect
high
fatal
rate
infect
human
also
asymptomat
octob
confirm
case
death
li
et
al
bat
serv
like
natur
reservoir
sinc
viru
nucleotid
ident
index
case
isol
egyptian
tomb
bat
memish
et
al
spread
human
like
come
infect
dromedari
camel
adney
et
al
azhar
et
al
host
rang
merscov
depend
bind
viral
protein
host
receptor
human
dipeptidyl
peptidas
four
also
known
raj
et
al
express
distribut
human
respiratori
tract
recent
well
character
meyerholz
et
al
interestingli
express
preferenti
local
alveolar
region
perhap
explain
mer
predominantli
manifest
infect
lower
respiratori
tract
human
preexist
pulmonari
diseas
increas
express
alveolar
epithelia
small
anim
typic
use
viral
diseas
research
mice
hamster
guinea
pig
ferret
natur
nonpermiss
merscov
infect
due
low
bind
effici
viral
protein
host
sutton
subbarao
contrast
rhesu
macaqu
common
marmoset
complet
homolog
human
allow
product
merscov
infect
occur
falzarano
et
al
munster
et
al
yao
et
al
new
zealand
white
rabbit
infect
merscov
viru
isol
upper
respiratori
tract
clinic
symptom
signific
histopatholog
chang
haagman
et
al
due
lack
strong
bind
affin
merscov
protein
murin
receptor
wildtyp
mice
suscept
merscov
infect
sever
approach
use
creat
suscept
murin
anim
model
merscov
infect
induc
express
one
approach
util
adenoviru
vector
express
transduc
mice
zhao
et
al
mice
develop
pneumonia
surviv
merscov
infect
merscov
infect
mice
global
express
result
id
ld
valu
tcid
respect
tao
et
al
thu
merscov
infect
transgen
mice
either
subleth
uniformli
lethal
depend
dose
inflammatori
infiltr
found
lung
brain
stem
mice
focal
infiltr
liver
well
anoth
strategi
use
transgen
mice
express
either
surfact
protein
c
cytokeratin
promot
li
et
al
merscov
infect
mice
result
uniformli
lethal
diseas
character
alveolar
edema
microvascular
thrombosi
mononuclear
clear
cell
infiltr
lung
brain
stem
also
impact
infect
express
ubiquit
express
promot
cytomegaloviru
also
uniformli
lethal
infect
predomin
lung
brain
involv
numer
tissu
also
impact
contain
viru
agraw
et
al
common
marmoset
infect
tcid
merscov
combin
oral
ocular
rout
capitul
sever
diseas
human
infect
falzarano
et
al
anim
manifest
moder
sever
clinic
diseas
interstiti
infiltr
lower
lung
lobe
two
nine
anim
becam
moribund
day
viral
rna
detect
nasal
throat
swab
variou
organ
blood
anim
indic
system
infect
histolog
anim
show
evid
acut
bronchial
interstiti
pneumonia
well
patholog
defect
infect
rhesu
macaqu
merscov
result
mild
clinic
diseas
character
transient
lung
infect
pneumonia
rhesu
macaqu
inocul
least
tcid
merscov
either
rout
combin
oral
ocular
inocul
result
mild
respiratori
ill
includ
nasal
swell
short
fever
anim
surviv
viral
rna
recov
nasal
swab
sampl
replic
viru
found
lung
tissu
mild
patholog
lesion
found
lung
radiograph
imag
lung
reveal
interstiti
infiltr
sign
pneumonia
yao
et
al
interestingli
mercov
infect
sever
marmoset
compar
rhesu
macaqu
falzarano
et
al
despit
find
speci
complet
homolog
human
within
domain
interact
viral
protein
host
factor
influenc
diseas
sever
yet
identifi
transgen
mous
model
express
ideal
initi
develop
screen
merscov
countermeasur
marmoset
use
final
select
character
filovirida
consist
three
genera
ebolaviru
marburgviru
newli
discov
group
cuevaviru
kuhn
thought
variou
speci
bat
natur
host
reservoir
virus
lethal
rate
human
evid
egyptian
rousett
bat
rousettu
aegyptiacu
natur
reservoir
marburgvirus
may
ebolavirus
jone
et
al
marburg
viru
marv
first
emerg
germani
laboratori
worker
contract
viru
agm
chlorocebu
aerthiop
ship
uganda
ebolavirus
sudan
zair
sudv
ebov
caus
nearli
simultan
outbreak
democrat
republ
congo
drc
recent
outbreak
ebov
west
africa
far
largest
suspect
probabl
confirm
case
death
bundibugyo
viru
bdbv
first
emerg
bundibugyo
uganda
confirm
case
two
ebolavirus
known
forest
tafv
previous
name
cote
divoir
ciebov
reston
restv
caus
major
outbreak
lethal
diseas
human
filoviru
diseas
human
character
aberr
innat
immun
number
clinic
symptom
fever
nausea
vomit
k
viral
diseas
arthralgiamyalgia
headach
sore
throat
diarrhea
abdomin
pain
anorexia
well
numer
other
mehedi
et
al
wauquier
et
al
approxim
patient
develop
petechia
greater
percentag
depend
specif
strain
may
develop
bleed
variou
site
gum
punctur
site
stool
etc
tabl
natur
transmiss
epidem
direct
contact
needl
stick
hospit
set
howev
much
research
interest
filovirus
primarili
stem
biodefens
need
particularli
aerosol
biothreat
im
ip
aerosol
model
develop
mice
hamster
guinea
pig
nhp
studi
pathogenesi
correl
immun
test
countermeasur
sinc
filovirus
high
lethal
rate
human
scientist
look
model
uniformli
lethal
stringent
test
efficaci
candid
vaccin
therapeut
one
issu
take
note
anim
model
develop
filoviru
infect
impact
particl
plaqueform
unit
pfu
ratio
lethal
wherein
possibl
increas
dose
could
actual
decreas
infect
due
immunogen
effect
produc
inact
virion
stock
addit
plaqu
assay
use
measur
live
virion
stock
may
greatli
underestim
true
quantiti
infecti
virion
prepar
alfson
et
al
smither
et
al
immunocompet
mice
success
infect
wildtyp
filovirus
due
control
infect
murin
type
interferon
respons
bray
howev
wildtyp
inbr
mice
suscept
filoviru
mous
adapt
serial
passag
mice
bray
et
al
marv
angola
particularli
resist
adapt
serial
passag
scid
mice
infect
caus
sever
diseas
balbc
mice
administ
ip
qiu
et
al
mice
patholog
similar
infect
human
includ
lymphopenia
thrombocytopenia
liver
damag
viremia
balbc
mice
strain
choic
ip
inocul
maebov
suscept
aerosol
rout
bray
et
al
zumbrun
et
al
aerosol
infect
immunocompet
mice
panel
bxd
balbc
x
dba
recombin
inbr
strain
screen
one
strain
particularli
suscept
airborn
maebov
lethal
low
high
dose
approxim
pfu
zumbrun
et
al
mice
develop
weight
loss
greater
succumb
infect
day
postexposur
aerosol
infect
model
util
wholebodi
exposur
chamber
expos
mice
age
week
maebov
aerosol
mass
median
aerodynam
diamet
mmad
approxim
geometr
standard
deviat
gsd
approxim
min
anoth
approach
use
immunodefici
mous
strain
scid
ko
ifn
receptor
ko
perforin
ko
wildtyp
ebov
inoculum
ip
aerosol
rout
bray
lever
et
al
zumbrun
et
al
mice
typic
monitor
clinic
diseas
score
base
activ
appear
weight
loss
moribund
condit
surviv
coagulopathi
hallmark
filoviru
infect
human
observ
bleed
subset
anim
failur
blood
sampl
coagul
late
infect
bray
et
al
liver
kidney
spleen
lung
tissu
taken
moribund
mice
patholog
characterist
filoviru
diseas
nhp
zumbrun
et
al
mous
studi
use
maebov
ebov
ip
mouseadapt
marv
model
also
avail
warfield
et
al
warfield
et
al
mamarv
maebov
model
particularli
use
screen
novel
antivir
compound
panchal
et
al
recent
model
creat
use
immunodefici
nsg
nonobes
diabet
nod
receptor
chain
knockout
mice
transplant
human
hematopoiet
stem
cell
umbil
cord
blood
mice
suscept
lethal
wt
nonadapt
ebov
ip
exposur
ludtk
et
al
transplant
mice
cellular
compon
fulli
function
adapt
human
immun
system
upon
ebov
brannan
et
al
lever
et
al
interestingli
inocul
infabr
mice
tafv
restv
result
clinic
sign
yet
anoth
strategi
use
knockout
mice
lack
possibl
receptor
filoviru
entri
niemannpick
mice
fulli
suscept
infect
ebov
mice
complet
resist
herbert
et
al
hamster
frequent
use
studi
cardiovascular
diseas
coagul
disord
thu
serv
basi
numer
viral
hemorrhag
fever
model
gowen
holbrook
herbert
et
al
ip
maebov
infect
model
develop
syrian
hamster
gowen
holbrook
herbert
et
al
tsuda
et
al
model
use
test
vesicular
stomat
viru
vector
vaccin
approach
util
male
syrian
hamster
infect
ld
maebov
viru
present
tissu
blood
collect
day
anim
succumb
diseas
day
infect
hamster
sever
coagulopathi
uncontrol
host
immun
respons
similar
observ
primat
ebihara
et
al
guinea
pig
model
filoviru
infect
develop
ip
aerosol
rout
use
guinea
pigadapt
ebov
gpebov
marv
gpmarv
choi
et
al
connolli
et
al
twenhafel
et
al
zumbrun
et
al
guinea
pig
model
filoviru
infect
quit
use
develop
fever
monitor
frequent
interv
telemetri
addit
anim
larg
enough
regular
blood
sampl
measur
coagul
defect
observ
infect
progress
comparison
ip
infect
outbr
guinea
pig
guinea
pigadapt
marv
angola
marv
ravn
reveal
similar
pathogenesi
cross
et
al
infect
either
strain
result
featur
diseas
similar
seen
human
nhp
infect
viremia
fever
coagulopathi
lymphopenia
elev
liver
enzym
alt
ast
thrombocytopenia
splenic
gastrointestin
hepat
lesion
gpmarvravn
delay
diseas
progress
rel
gpmarvang
hartley
guinea
pig
expos
aerosol
gpebov
develop
lethal
interstiti
pneumonia
contrast
subq
infect
guinea
pig
aerosol
ebov
challeng
nhp
natur
human
infect
twenhafel
et
al
subq
aerosol
exposur
guinea
pig
gpebov
result
mild
lesion
liver
spleen
aerosol
exposur
gpebov
uniformli
lethal
high
low
dose
pfu
target
dose
lethal
drop
low
less
pfu
present
dose
airborn
gpmarv
protract
diseas
seen
anim
unpublish
observ
zumbrun
et
al
weight
loss
common
find
guinea
pig
expos
gpebov
gpmarv
fever
becom
appar
day
occur
rapidli
gpebov
expos
guinea
pig
gpmarv
exposur
lymphocyt
neutrophil
increas
earlier
part
diseas
platelet
level
steadili
drop
diseas
progress
increas
coagul
time
seen
earli
day
postexposur
blood
chemistri
ie
alt
ast
alkp
bun
indic
problem
liver
kidney
function
also
alter
late
diseas
cours
transmiss
ebov
document
swine
nhp
via
respiratori
tract
kobing
et
al
guinea
pig
use
establish
transmiss
model
wong
et
al
b
nonexpos
guinea
pig
place
cage
infect
guinea
pig
day
postexposur
gpebov
guinea
pig
challeng
intanas
like
transmit
viru
naiv
cagem
expos
ip
rout
nhp
model
filoviru
infect
prefer
model
advanc
diseas
character
test
countermeasur
close
mimic
diseas
immun
correl
seen
human
dye
et
al
old
world
primat
primarili
use
develop
ip
im
aerosol
model
filoviru
infect
twenhafel
et
al
uniformli
lethal
filoviru
model
develop
viru
strain
cynomolgu
macaqu
rhesu
macaqu
lesser
degre
agm
alv
et
al
carrion
et
al
davi
et
al
hensley
et
al
reed
et
al
zumbrun
et
al
lowpassag
human
isol
passag
anim
sought
develop
nhp
model
satisfi
food
drug
administr
fda
anim
rule
ebovmakona
strain
respons
recent
larg
outbreak
west
africa
compar
prototyp
ebov
strain
marzi
et
al
diseas
cyno
similar
virus
diseas
progress
delay
ebovmakona
delay
well
lower
fatal
rate
epidem
compar
outbreak
suggest
ebovmakona
less
virul
larg
number
case
ebov
outbreak
brought
light
previous
underappreci
eye
patholog
ocular
viral
persist
survivor
survivor
nhp
filoviru
infect
infrequ
necrot
scleriti
conjunct
ocular
patholog
observ
ebovinfect
anim
alv
et
al
promin
featur
filoviru
infect
nhp
onset
fever
day
postexposur
viremia
lymphopenia
tachycardia
azotemia
alter
liver
function
enzym
alt
ast
alkp
decreas
platelet
increas
coagul
time
petechi
rash
common
sign
filoviru
diseas
may
frequent
observ
cynomolgu
macaqu
nhp
speci
zumbrun
et
al
immunolog
paramet
evalu
b
natur
killer
cell
greatli
diminish
infect
progress
fernando
et
al
cytokin
storm
occur
rise
tnf
fernando
et
al
howev
also
evid
transcript
profil
circul
immun
cell
earli
immun
respons
skew
toward
respons
connor
et
al
strikingli
anim
surviv
challeng
may
delay
product
inflammatori
cytokin
chemokin
martin
et
al
clinic
diseas
paramet
may
slightli
delay
onset
aerosol
model
dyspnea
late
infect
promin
featur
diseas
aerosol
exposur
zumbrun
et
al
aerosol
filoviru
infect
nhp
result
earli
infect
respiratori
lymphoid
tissu
dendrit
cell
alveolar
macrophag
blood
monocyt
fibroblast
reticular
cell
follow
spread
region
lymph
node
multipl
organ
ewer
et
al
twenhafel
et
al
number
pronounc
patholog
find
includ
multifoc
hepat
necrosi
fibrin
accumul
particularli
within
liver
spleen
aerosol
marv
infect
rhesu
signific
patholog
includ
destruct
tracheobronchi
mediastin
lymph
node
ewer
et
al
lymphocytolysi
lymphoid
deplet
also
observ
alv
et
al
multilead
surgic
implant
telemetri
devic
use
continu
collect
temperatur
blood
pressur
heart
rate
activ
level
blood
pressur
drop
anim
becom
moribund
heart
rate
variabl
standard
deviat
heart
rate
alter
late
infect
zumbrun
et
al
recent
develop
telemetri
devic
also
aid
plethysmographi
measur
respiratori
minut
volum
accur
deliveri
present
dose
aerosol
exposur
standard
filovirusinfect
nhp
euthanasia
criteria
also
develop
enhanc
reproduc
studi
evalu
therapeut
vaccin
countermeasur
warren
et
al
filoviru
infect
common
marmoset
callithrix
jacchu
also
viabl
model
studi
diseas
cours
respiratori
infect
marmoset
marv
result
lethal
infect
fever
hemorrhag
transient
rash
dissemin
viral
infect
increas
liver
function
enzym
coagulopathi
hepat
histolog
lesion
particularli
kidney
liver
smither
et
al
marmoset
similarli
suscept
infect
ebov
kikwit
smither
et
al
thu
ebov
marv
infect
marmoset
produc
featur
diseas
similar
nhp
human
hendra
nipah
viru
unusu
within
paramyxovirida
famili
given
infect
larg
rang
mammalian
host
virus
group
genu
henipaviru
natur
reservoir
virus
fruit
bat
genu
pteropu
hendra
nipah
abil
caus
sever
diseas
human
potenti
high
case
fatal
rate
rockx
et
al
outbreak
due
nipah
viru
recogn
malaysia
singapor
bangladesh
india
hendra
viru
outbreak
yet
report
outsid
australia
lubi
et
al
b
hendra
first
member
genu
identifi
initi
associ
acut
respiratori
diseas
hors
human
case
link
transmiss
close
contact
infect
hors
confirm
case
direct
transmiss
bat
human
nipah
distinct
transmiss
among
although
exact
rout
unknown
homaira
et
al
viru
suscept
ph
temperatur
desicc
thu
close
contact
hypothes
need
success
transmiss
fogarti
et
al
virus
tropism
neurolog
respiratori
tract
incub
period
hendra
viru
day
mark
flulik
ill
symptom
initi
stage
includ
myalgia
headach
lethargi
sore
throat
vomit
hanna
et
al
diseas
progress
continu
pneumon
encephalit
manifest
person
succumb
multiorgan
failur
playford
et
al
nipah
viru
incub
period
day
week
goh
et
al
much
like
hendra
first
sign
diseas
nondescript
sever
neurolog
symptom
subsequ
develop
includ
enceph
seizur
progress
coma
within
h
lo
rota
survivor
infect
typic
make
full
recoveri
howev
suffer
perman
sequela
includ
persist
convuls
tan
chua
time
approv
vaccin
antivir
treatment
pure
support
anim
model
use
test
novel
vaccin
therapeut
also
deduc
earli
event
diseas
document
human
case
termin
stage
best
small
anim
model
syrian
golden
hamster
due
high
suscept
henipavirus
clinic
sign
upon
infect
recapitul
diseas
cours
human
includ
acut
enceph
respiratori
distress
challeng
anim
die
within
day
postinfect
progress
diseas
timelin
highli
depend
dose
rout
infect
inocul
lead
imbal
limb
paralysi
lethargi
breath
difficulti
wherea
ip
result
tremor
paralysi
within
h
death
viru
detect
lung
brain
spleen
kidney
heart
spinal
cord
urin
brain
highest
titer
model
use
vaccin
passiv
protect
studi
guillaum
et
al
rockx
et
al
wong
et
al
guinea
pig
model
wide
use
due
lack
respiratori
diseas
upon
challeng
torresvelez
et
al
williamson
et
al
inocul
hendra
viru
via
subq
rout
lead
gener
vascular
diseas
mortal
clinic
sign
appar
day
postinfect
death
occur
within
day
cn
involv
higher
inoculum
associ
develop
enceph
cn
lesion
id
inject
lead
diseas
although
anim
abl
seroconvert
upon
challeng
inoculum
sourc
affect
clinic
progress
nipah
viru
challeng
caus
diseas
upon
ip
inject
result
weight
loss
transient
fever
day
viru
shed
urin
present
brain
spleen
lymph
node
ovari
uteru
urinari
bladder
hooper
et
al
ferret
infect
hendra
nipah
viru
display
clinic
diseas
seen
hamster
model
human
case
bossart
et
al
pallist
et
al
upon
inocul
oronas
rout
ferret
develop
sever
pulmonari
neurolog
diseas
within
day
includ
fever
cough
dyspnea
lesion
develop
ferret
brain
lesser
degre
seen
human
cat
also
util
anim
model
henipavirus
diseas
symptom
depend
upon
rout
infect
incub
period
day
lead
respiratori
neurolog
symptom
mungal
et
al
johnston
et
al
westburi
et
al
model
proven
use
vaccin
efficaci
studi
squirrel
agm
repres
nhp
model
squirrel
monkey
nipah
viru
introduc
either
iv
rout
subsequ
lead
clinic
sign
similar
human
although
challeng
result
milder
diseas
upon
challeng
anim
develop
diseas
manifest
includ
anorexia
dyspnea
acut
respiratori
syndrom
neurolog
involv
character
uncoordin
motor
skill
loss
conscious
coma
viral
rna
detect
lung
brain
liver
kidney
spleen
lymph
node
found
upon
iv
challeng
marianneau
et
al
agm
consist
model
virus
inocul
virus
result
mortal
death
within
day
postinfect
hendra
nipah
virus
respect
anim
develop
sever
respiratori
neurolog
diseas
gener
vascul
rockx
et
al
reservoir
virus
grayhead
fruit
bat
experiment
challeng
due
statu
host
organ
henipavirus
bat
develop
clinic
diseas
howev
hendra
viru
detect
kidney
heart
spleen
fetal
tissu
nipah
viru
locat
urin
pig
develop
respiratori
diseas
upon
infect
nipah
hendra
virus
berhan
et
al
li
et
al
middleton
et
al
oral
inocul
produc
clinic
diseas
subq
inject
repres
success
rout
infect
live
viru
isol
oropharynx
earli
day
postinfect
nipah
viru
also
transmit
pig
nipah
viru
abl
induc
neurolog
symptom
pig
even
though
viru
present
neurolog
tissu
regardless
symptom
weingartl
et
al
within
pig
model
appear
nipah
viru
greater
tropism
respiratori
tract
hendra
neurolog
system
hors
also
abl
develop
sever
respiratori
tract
infect
accompani
fever
gener
weak
upon
exposur
nipah
hendra
virus
oronas
inocul
led
system
diseas
viral
rna
detect
nasal
swab
within
day
marsh
et
al
williamson
et
al
anim
die
within
day
postexposur
interstiti
pneumonia
necrosi
alveoli
murray
et
al
b
viru
could
detect
major
system
mice
rat
rabbit
chicken
dog
test
nonpermiss
infect
westburi
et
al
wong
et
al
suckl
balbc
mice
succumb
infect
viru
inocul
intracrani
mungal
et
al
exposur
nipah
induc
clinic
diseas
howev
evid
subclin
infect
lung
follow
euthanasia
mice
dup
et
al
addit
human
lung
xenograph
model
nsg
mice
demonstr
human
lung
highli
suscept
nipah
viral
replic
damag
valbuena
et
al
embryon
chicken
egg
inocul
nipah
viru
lead
univers
fatal
diseas
within
day
postinfect
tanimura
et
al
annual
respiratori
syncyti
viru
rsv
respons
lower
respiratori
tract
infect
million
children
age
turn
result
million
hospit
approxim
death
nair
et
al
within
unit
state
hospit
cost
alon
amount
million
dollar
per
year
paramor
et
al
outbreak
common
winter
yusuf
et
al
viru
transmit
larg
respiratori
droplet
replic
initi
within
nasopharynx
spread
lower
respiratori
tract
incub
viru
day
rsv
highli
virul
lead
asymptomat
infect
collin
graham
diseas
manifest
highli
depend
upon
age
individu
rsv
infect
neonat
produc
nonspecif
symptom
includ
overal
failur
thrive
apnea
feed
difficulti
infant
present
mild
upper
respiratori
tract
diseas
could
develop
bronchiol
bronchopneumonia
contract
rsv
age
result
increas
chanc
develop
childhood
asthma
wu
et
al
young
children
develop
recurr
wheez
adult
exacerb
previous
exist
respiratori
condit
falsey
et
al
common
clinic
symptom
runni
nose
sneez
cough
accompani
fever
mortal
rate
rsv
hospit
children
greatest
burden
diseas
seen
month
old
ruuskanen
ogra
hematopoiet
stem
cell
transplant
patient
solid
organ
transplant
patient
copd
patient
particularli
vulner
rsv
infect
mortal
rate
upon
infect
anderson
et
al
although
almost
rsv
vaccin
candid
preclin
clinic
phase
licens
vaccin
avail
ribavirin
usag
recommend
routin
treatment
american
academi
pediatr
subcommitte
diagnosi
manag
bronchiol
higgin
et
al
kim
chang
anim
model
rsv
develop
hope
formul
effect
safe
vaccin
unlik
formalininactiv
rsv
firsv
vaccin
vaccin
induc
sever
respiratori
ill
infant
receiv
vaccin
subsequ
infect
live
viru
kim
et
al
mice
use
model
rsv
infect
although
high
inocul
need
achiev
clinic
symptom
jafri
et
al
stark
et
al
strain
choic
crucial
reproduc
physiolog
relev
respons
stoke
et
al
age
affect
primari
diseas
manifest
graham
et
al
howev
play
role
later
sequela
show
increas
airway
hyperreact
primari
rsv
infect
produc
increas
breath
airway
obstruct
jafri
et
al
van
schaik
et
al
viru
detect
earli
day
reach
maximum
titer
day
postinfect
clinic
ill
defin
mous
weight
loss
ruffl
fur
oppos
runni
nose
sneez
cough
seen
human
human
mous
model
recent
develop
inocul
challeng
mice
experienc
weight
loss
demonstr
humor
cellular
immun
respons
infect
sharma
et
al
cotton
rat
use
given
rsv
abl
replic
high
titer
within
lung
detect
upper
lower
airway
inocul
boukhvalova
et
al
niewiesk
princ
viral
replic
greater
cotton
rat
model
mous
model
wyde
et
al
cotton
rat
develop
mild
moder
bronchiol
pneumonia
griev
et
al
princ
et
al
although
age
appear
factor
clinic
outcom
report
older
cotton
rat
tend
take
longer
achiev
viral
clearanc
viral
load
peak
day
drop
level
detect
day
histopatholog
lung
appear
similar
human
infect
piazza
et
al
model
limit
use
model
human
immun
respons
infect
challeng
viru
induc
respons
cotton
rat
wherea
human
tend
respons
skew
toward
culley
et
al
dakhama
et
al
rippl
et
al
firsv
diseas
recapitul
upon
challeng
live
viru
vaccin
twice
firsv
chinchilla
challeng
experiment
rsv
via
inocul
viru
permiss
within
nasopharynx
eustachian
tube
anim
display
acut
respiratori
tract
infect
model
therefor
use
studi
mucos
immun
infect
gitiban
et
al
ferret
infect
found
detect
rsv
throat
swab
day
postinfect
posit
qpcr
day
immunocompromis
ferret
observ
higher
viral
load
accompani
detect
viral
replic
upper
respiratori
tract
stittelaar
et
al
chimpanze
permiss
replic
clinic
symptom
rsv
includ
rhinorrhea
sneez
cough
adult
squirrel
monkey
newborn
rhesu
macaqu
infant
cebu
monkey
also
challeng
exhibit
diseas
symptom
high
level
viral
replic
belsh
et
al
bonnet
monkey
develop
inflammatori
respons
day
viral
rna
detect
bronchial
alveolar
cell
simo
et
al
chimpanze
model
proven
use
vaccin
studi
hancock
et
al
teng
et
al
sheep
also
challeng
experiment
sinc
develop
respiratori
diseas
expos
ovin
rsv
meyerholz
et
al
lamb
also
suscept
human
respiratori
syncyti
infect
olivi
et
al
sow
et
al
inocul
intratrach
lamb
develop
upper
respiratori
tract
infect
cough
day
lamb
went
develop
lower
respiratori
diseas
includ
bronchiol
pneumonia
resolv
within
day
rsv
replic
peak
day
rapidli
declin
studi
respiratori
diseas
sheep
benefici
given
share
structur
featur
human
plopper
et
al
scheerlinck
et
al
influenza
virus
consist
three
type
influenza
b
c
base
antigen
differ
influenza
classifi
subtyp
ha
na
subtyp
known
season
influenza
common
infect
usual
caus
selflimit
febril
ill
upper
respiratori
symptom
malais
resolv
within
day
taubenberg
moren
rate
infect
estim
gener
popul
result
billion
dollar
loss
annual
medic
cost
reduc
workforc
product
approxim
peopl
unit
state
die
year
season
influenza
dushoff
et
al
thu
vaccin
therapeut
play
critic
role
control
infect
develop
use
anim
model
ongo
braun
et
al
influenza
viru
replic
upper
lower
airway
peak
approxim
postexposur
infect
sever
infant
children
age
peopl
age
immunocompromis
individu
viral
pneumon
pneumonia
develop
bacteri
superinfect
result
pneumonia
sepsi
barnard
glezen
pneumonia
secondari
bacteri
infect
streptococcu
pneumonia
streptococcu
pyogen
neisseria
meningitid
rare
staphylococcu
aureu
common
viral
pneumonia
influenza
viru
account
influenza
associ
fatal
alonso
et
al
ison
lee
speshock
et
al
death
often
due
ard
occur
earli
day
onset
symptom
lung
histopatholog
sever
case
may
includ
dad
alveolar
edema
damag
hemorrhag
fibrosi
inflamm
taubenberg
moren
avian
strain
influenza
lethal
rate
around
known
case
like
viru
preferenti
bind
cell
lower
respiratori
tract
thu
potenti
global
spread
major
concern
matrosovich
et
al
wang
et
al
anoth
avian
influenza
strain
infect
peopl
implic
death
approxim
infect
peopl
known
exposur
bird
evid
sustain
spread
human
virus
great
concern
pandem
potenti
zhang
et
al
frequent
use
anim
model
influenza
infect
includ
mice
ferret
nhp
thorough
guid
work
mous
guinea
pig
ferret
cynomolgu
model
publish
kroez
et
al
swine
frequent
util
also
potenti
use
model
influenza
research
sinc
share
mani
similar
human
anatomi
genet
suscept
pathogenesi
rajao
vincent
lethal
rate
vari
viru
strain
use
without
adapt
dose
rout
inocul
age
genet
background
anim
variou
anim
model
captur
differ
diseas
caus
influenza
benign
sever
super
infect
sepsi
sever
ard
neurolog
manifest
barnard
also
model
util
season
avian
strain
develop
studi
transmiss
import
understand
potenti
lethal
strain
spread
among
human
mous
model
influenza
infect
predict
antivir
activ
tissu
tropism
human
use
test
evalu
vaccin
gilbert
mcleay
hagenaar
et
al
ortigoza
et
al
inocul
rout
util
approxim
inoculum
nare
anesthet
mice
exposur
may
also
small
particl
aerosol
contain
influenza
mmad
inbr
strain
suscept
particularli
frequent
use
balbc
follow
mice
male
femal
equival
diseas
influenza
gener
infecti
younger
g
mice
mice
somewhat
limit
use
character
immun
respons
influenza
inbr
laboratori
mice
lack
mxa
gene
import
part
human
innat
immun
respons
influenza
infect
mous
homolog
mxa
defect
inbr
mous
strain
staeh
haller
mice
knockedin
gene
higher
influenza
strain
wildtyp
background
mice
grimm
et
al
weight
loss
reduc
weight
gain
decreas
activ
huddl
ruffl
fur
increas
respir
common
clinic
sign
influenza
infect
mice
virul
strain
mice
may
requir
euthanasia
earli
h
postexposur
mortal
occur
day
postexposur
accompani
decreas
rectal
temperatur
sidwel
smee
puls
oximet
read
measur
blood
gase
oxygen
satur
also
use
determin
impact
influenza
infect
respiratori
function
sidwel
et
al
viru
isol
bronchial
lavag
bal
fluid
throughout
infect
tissu
euthanasia
influenza
strain
mild
moder
pathogen
diseas
nonleth
viru
replic
detect
within
lung
usual
organ
increas
serum
lung
weight
also
frequent
occur
howev
mice
infect
influenza
develop
fever
dyspnea
nasal
exud
sneez
cough
mice
experiment
infect
influenza
b
viru
gener
requir
adapt
produc
clinic
sign
mice
express
receptor
influenza
attach
respiratori
tract
howev
distribut
vari
sa
predomin
sa
subtyp
usual
need
adapt
mice
virus
requir
adapt
odonnel
subbarao
adapt
mice
infect
intratrach
intranas
viru
isol
lung
reinfect
mice
process
repeat
number
time
adapt
influenza
strain
produc
sever
diseas
system
spread
neurotrop
pandem
influenza
viru
caus
lethal
infect
mice
without
adapt
gao
et
al
taubenberg
infect
mice
result
viremia
viral
replic
multipl
organ
system
sever
lung
patholog
fulmin
diffus
interstiti
pneumonia
pulmonari
edema
high
level
proinflammatori
cytokin
mark
lymphopenia
dybe
et
al
gubareva
et
al
lu
et
al
human
virul
attribut
damag
caus
overact
host
immun
respons
addit
mice
infect
influenza
viru
produc
sever
lung
patholog
oxygen
satur
level
decreas
increas
pneumonia
barnard
et
al
reassort
influenza
virus
viru
lowpathogen
avian
viru
also
induc
diseas
mice
without
adapt
superinfect
model
subleth
dose
influenza
given
mice
follow
day
later
inocul
subleth
dose
bacteri
strain
pneumonia
pyogen
chausse
et
al
morbid
character
inflamm
lung
bacteremia
begin
coupl
day
superinfect
may
continu
week
least
one
transmiss
model
also
develop
mice
influenza
transmiss
rate
among
cagem
achiev
infect
aerosol
rout
cocag
h
schulman
rat
sd
inocul
ratadapt
develop
inflammatori
infiltr
cytokin
bronchoalveolar
lavag
fluid
lethal
histopatholog
chang
daniel
et
al
addit
influenza
transmiss
model
develop
guinea
pig
altern
ferret
lowen
et
al
cotton
rat
sigmodon
hispidu
use
test
vaccin
therapeut
limit
number
studi
eichelberg
et
al
cotton
rat
advantag
mice
immun
system
similar
human
includ
presenc
mx
gene
influenza
virus
adapt
eichelberg
et
al
ottolini
et
al
nasal
pulmonari
tissu
cotton
rat
infect
unregul
cytokin
lung
viral
load
peak
h
postexposur
viru
clear
lung
day
nare
day
anim
bronchial
alveolar
damag
pneumonia
week
also
aureu
superinfect
model
cotton
rat
braun
et
al
coinfect
result
bacteremia
high
bacteri
load
lung
peribronchiol
pneumon
alveol
hypothermia
higher
mortal
domest
ferret
mustela
putoriu
furo
frequent
anim
speci
choic
influenza
anim
studi
suscept
clinic
sign
peak
viru
shed
kinet
transmiss
local
express
cytokin
mrna
patholog
resembl
human
lambkin
et
al
main
et
al
mclaren
butchko
like
human
ferret
exclus
express
act
receptor
influenza
viru
featur
like
contribut
suscept
ferret
humanadapt
influenza
viru
strain
ng
et
al
glycom
character
ferret
respiratori
tract
tissu
demonstr
similar
differ
human
term
potenti
glycan
bind
site
influenza
viru
jia
et
al
ferret
also
airway
morpholog
respiratori
cell
type
distribut
influenza
receptor
sa
sa
within
airway
similar
human
van
riel
et
al
influenza
first
isol
ferret
infect
throat
wash
human
harbor
infect
ferret
model
sinc
use
test
efficaci
vaccin
therapeut
treatment
huber
et
al
lambkin
et
al
main
et
al
perform
influenza
studi
ferret
anim
serolog
neg
circul
influenza
virus
infect
anim
place
separ
room
uninfect
anim
anim
must
place
room
uninfect
ferret
handl
infect
ferret
anesthet
ferret
experiment
expos
influenza
inocul
ml
contain
approxim
egg
id
dropwis
nostril
howev
larger
inoculum
volum
ml
also
explor
appropri
yield
sever
consist
respiratori
tract
patholog
like
larger
inoculum
wide
distribut
lower
respiratori
tract
moor
et
al
video
track
assign
valu
activ
level
ferret
aid
ferret
studi
elimin
need
collect
subject
arbitrari
clinic
score
oh
et
al
viral
replic
upper
respiratori
tract
typic
measur
nasal
wash
viru
also
measur
bronchoalveolar
lavag
fluid
use
noninvas
techniqu
lee
et
al
influenza
type
b
natur
infect
ferret
result
acut
ill
usual
last
day
mild
moder
virul
strain
maher
destefano
ferret
suscept
influenza
influenza
b
strain
also
suscept
avian
influenza
strain
without
adapt
zitzow
et
al
howev
local
immun
respons
within
respiratori
tract
ferret
infect
influenza
b
character
similar
carolan
et
al
virul
degre
pneumon
caus
differ
influenza
subtyp
strain
vari
mild
sever
gener
mirror
seen
human
stark
et
al
nonadapt
mild
moder
virul
ferret
sequenc
ferret
genom
allow
character
ferret
host
respons
use
rnaseq
analysi
distinct
signatur
obtain
depend
particular
influenza
strain
inocul
ferret
also
help
sequenc
character
influenza
ferret
infectom
differ
stage
infect
immun
ferret
leon
et
al
sinc
influenza
infect
particularli
devast
elderli
popul
age
ferret
model
influenza
infect
develop
paquett
et
al
featur
associ
increas
clinic
diseas
weaken
hemagglutinin
antibodi
gener
attenu
respons
pregnant
breastfeed
women
infant
also
suscept
sever
ill
influenza
viru
studi
dynam
breastfeed
motherinf
ferret
influenza
infect
model
creat
paquett
et
al
notabl
mammari
gland
harbor
viru
transcript
analysi
show
downregul
milk
product
gene
support
develop
therapi
ferret
influenza
model
pharmacokineticpharmacodynam
studi
antivir
drug
also
develop
reddi
et
al
critic
model
ensur
pronounc
clinic
sign
robust
viral
replic
upon
influenza
infect
strain
low
virul
predomin
replic
nasal
turbin
ferret
clinic
sign
diseas
indic
ferret
similar
human
mild
respiratori
diseas
sneez
nasal
secret
contain
viru
fever
weight
loss
high
viral
titer
inflammatori
infiltr
airway
bronchiti
pneumonia
svitek
et
al
replic
upper
lower
airway
associ
sever
diseas
greater
mortal
addit
increas
express
proinflammatori
mediat
reduc
express
antiinflammatori
mediat
lower
respiratori
tract
ferret
correl
sever
diseas
lethal
outcom
ferret
develop
sever
lethargi
greater
interferon
respons
transient
lymphopenia
replic
respiratori
tract
brain
organ
peng
et
al
zitzow
et
al
immunocompromis
human
influenza
ill
greater
durat
complic
immunocompromis
ferret
infect
influenza
similarli
prolong
viru
shed
van
der
vri
et
al
interestingli
antivir
resist
emerg
human
ferret
immunocompromis
statu
infect
influenza
alveolar
macrophag
deplet
ferret
infect
pandem
influenza
also
sever
diseas
greater
viral
replic
lung
greater
induct
inflammatori
chemokin
kim
et
al
superinfect
model
resembl
mice
develop
instil
influenza
ferret
follow
inocul
pneumonia
day
later
peltola
et
al
typic
result
otiti
media
sinus
pneumonia
transmiss
model
ferret
recent
met
worldwid
media
attent
controversi
regard
studi
enserink
fouchier
et
al
herfst
et
al
oh
et
al
gener
subtyp
transmit
easili
aerosol
respiratori
droplet
munster
et
al
concern
isol
human
pathogen
readili
transmiss
ferret
larger
respiratori
droplet
smaller
particl
aerosol
kreijtz
et
al
richard
et
al
zhang
et
al
becam
transmiss
adopt
four
mutat
spread
ferret
separ
cage
imai
et
al
transmiss
occur
readili
height
pyrexia
particular
occur
fever
detect
robert
et
al
ferrettoferret
transmiss
mouseadapt
influenza
b
viru
also
demonstr
kim
et
al
sinc
ferret
expens
cumbersom
influenza
infect
character
transmiss
model
develop
guinea
pig
howev
newer
model
infrequ
util
thu
far
lowen
et
al
old
new
world
primat
suscept
influenza
infect
advantag
ferret
mous
model
defici
vaccin
studi
lack
correl
hemagglutin
inhibit
murphi
et
al
old
world
primat
cynomolgu
macaqu
macaca
fasciculari
frequent
util
studi
vaccin
antivir
drug
therapi
stittelaar
et
al
infect
cyno
similar
human
rimmelzwaan
et
al
cyno
develop
fever
ard
upon
inocul
necrot
bronchial
interstiti
pneumonia
nhp
challeng
multipl
rout
k
viral
diseas
ocular
nasal
tracheal
simultan
pfu
per
site
viru
antigen
primarili
local
tonsil
pulmonari
tissu
infect
cyno
result
fever
lethargi
nasal
discharg
anorexia
weight
loss
nasal
tracheal
wash
patholog
histopatholog
chang
alveolar
bronchial
inflamm
caus
high
mortal
rate
due
aberr
immun
respons
ard
lethal
human
lethal
kobasa
et
al
ard
mortal
also
occur
pathogen
strain
nhp
show
reduc
suscept
less
virul
strain
odonnel
subbarao
influenzainfect
rhesu
macaqu
repres
mild
diseas
model
vaccin
therapeut
efficaci
studi
baa
et
al
host
microarray
qrtpcr
prove
use
analysi
infect
lung
tissu
nhp
model
includ
influenza
infect
pigtail
macaqu
mild
diseas
model
infect
new
world
primat
squirrel
cebu
monkey
baskin
et
al
domest
pig
model
develop
vaccin
studi
swine
flu
pig
suscept
natur
natur
intermedi
host
readili
suscept
isoda
et
al
lipatov
et
al
pig
infect
influenza
may
fever
anorexia
respiratori
sign
dyspnea
cough
mortal
rare
van
der
laan
et
al
size
space
requir
make
anim
difficult
work
although
develop
minipig
model
may
provid
easier
use
altern
cat
dog
influenza
model
primarili
util
studi
suscept
thought
anim
could
act
sentinel
could
serv
transmit
viru
human
gies
et
al
rimmelzwaan
et
al
model
gener
use
better
understand
diseas
human
test
vaccin
antivir
rift
valley
fever
viru
rvfv
caus
epizoot
human
epidem
africa
rvfv
mainli
infect
livestock
sheep
cattl
goat
etc
day
incub
period
anim
show
sign
fever
hepat
abort
hallmark
diagnost
sign
known
among
farmer
balkhi
memish
mosquito
vector
unpasteur
milk
aerosol
infect
anim
bodi
fluid
direct
contact
infect
anim
import
rout
transmiss
human
abuelyaze
et
al
mundel
gear
period
rvfv
caus
wide
rang
sign
symptom
human
rang
asymptomat
sever
diseas
hepat
vision
loss
enceph
hemorrhag
fever
ikegami
makino
laughlin
et
al
peter
linthicum
depend
sever
diseas
symptom
start
hospit
patient
might
die
day
day
diseas
onset
ikegami
makino
hepat
failur
renal
failur
dic
enceph
demonstr
within
patient
postmortem
examin
live
domest
anim
especi
sheep
goat
use
develop
anim
model
rvfv
weingartl
et
al
studi
indic
goat
resist
diseas
compar
sheep
viremia
goat
lower
shorter
durat
anim
develop
fever
suscept
influenc
rout
infect
breed
anim
rvfv
strain
growth
condit
well
passag
histori
therefor
might
difficult
establish
anim
model
domest
rumin
mice
one
suscept
anim
speci
rvfv
infect
sever
mous
model
includ
balbc
ifnar
mbtpa
expos
rvfv
via
parent
aerosol
rout
infect
ross
et
al
subq
ip
rout
infect
caus
acut
hepat
lethal
enceph
late
stage
diseas
mice
mim
smith
et
al
mice
start
show
sign
decreas
activ
ruffl
fur
day
postexposur
immedi
follow
sign
becom
letharg
gener
die
day
postexposur
ocular
diseas
hemorrhag
form
diseas
observ
mous
model
far
ikegami
makino
increas
viremia
tissu
tropism
report
mice
smith
et
al
increas
liver
enzym
lymphopenia
observ
sick
mice
aerosol
rvfv
caus
faster
sever
neuropathi
mice
compar
parent
rout
dodd
et
al
reed
et
al
liver
target
organ
follow
aerosol
exposur
liver
failur
result
fatal
rat
gerbil
also
suscept
rvfv
infect
rat
suscept
depend
rat
strain
util
challeng
model
rout
exposur
also
note
age
depend
suscept
rat
wistarfurth
brown
norway
strain
young
rat
highli
suscept
rvfv
infect
fisher
buffalo
lewi
strain
old
rat
demonstr
resist
infect
via
subq
rout
infect
findlay
howard
peter
slone
similar
patholog
chang
liver
damag
encephalopathi
observ
rat
mice
recent
studi
bale
et
al
show
aerosol
rvfv
caus
similar
diseas
outcom
wistarfurth
aci
rat
lewi
rat
develop
fatal
enceph
much
sever
subq
rout
infect
liver
involv
gerbil
model
anim
die
sever
enceph
mortal
rate
depend
strain
use
dose
given
gerbil
anderson
et
al
similar
rat
model
suscept
gerbil
also
depend
age
natur
histori
studi
syrian
hamster
indic
liver
target
organ
highli
elev
alt
level
viral
titer
scharton
et
al
lethargi
ruffl
fur
hunch
postur
observ
hamster
day
postsubq
inocul
diseas
uniformli
lethal
day
postexposur
model
success
use
test
antivir
rvfv
scharton
et
al
studi
thu
far
show
rvfv
caus
uniform
lethal
nhp
model
ip
iv
aerosol
rout
util
develop
nhp
model
rhesu
macaqu
cynomolgu
macaqu
african
monkey
south
american
monkey
nhp
speci
use
effort
monkey
show
varieti
sign
rang
febril
diseas
hemorrhag
diseas
mortal
tempor
viremia
increas
coagul
paramet
pt
aptt
decreas
platelet
sign
observ
nhp
anim
succumb
diseas
show
similar
pathogenesi
human
patholog
chang
liver
hemorrhag
diseas
ocular
involv
model
smith
et
al
compar
iv
subq
rout
infect
common
marmoset
rhesu
macaqu
peng
et
al
marmoset
suscept
rvfv
infect
rhesu
macaqu
mark
viremia
acut
hepat
late
onset
enceph
increas
liver
enzym
observ
speci
necropsi
result
show
enlarg
liver
marmoset
expos
iv
subq
rout
although
gross
lesion
brain
marmoset
histopatholog
show
enceph
brain
challeng
marmoset
recent
studi
hartman
et
al
demonstr
aerosol
rvfv
caus
mild
fever
cynomolgu
macaqu
rhesu
macaqu
agm
marmoset
enceph
succumb
diseas
day
postexposur
contrast
lethal
model
brain
target
organ
agm
marmoset
although
chang
observ
ast
level
alp
level
increas
marmoset
littl
chang
observ
hepat
enzym
level
agm
lack
inform
regard
human
diseas
concern
aerosol
rout
exposur
make
difficult
evalu
anim
model
crimeancongo
hemorrhag
fever
viru
cchfv
gener
circul
natur
unnot
enzoot
tickvertebratetick
cycl
similar
zoonot
agent
appear
produc
littl
diseas
natur
host
caus
sever
diseas
human
cchfv
transmit
human
ixodid
tick
direct
contact
sick
animalshuman
bodi
fluid
animalshuman
ergonul
whitehous
incub
prehemorrhag
hemorrhag
convalesc
four
phase
diseas
seen
human
incub
period
last
day
prehemorrag
phase
patient
show
sign
nonspecif
flulik
diseas
approxim
week
hemorrhag
period
result
circulatori
shock
dic
patient
mardani
keshtkarjahromi
swanepoel
et
al
year
sever
attempt
made
establish
anim
model
cchf
adult
mice
guinea
pig
hamster
rat
rabbit
sheep
nhp
etc
fagbami
et
al
nalca
whitehous
shepherd
et
al
smirnova
recent
anim
manifest
diseas
newborn
mous
infant
mice
ip
infect
cchfv
result
fatal
around
day
postinfect
tignor
hanham
pathogenesi
studi
show
viru
replic
first
detect
liver
subsequ
spread
blood
serum
viru
detect
late
diseas
cours
tissu
includ
heart
day
brain
day
recent
studi
util
knockout
adult
mice
success
develop
lethal
small
anim
model
cchfv
infect
bent
et
al
bereczki
et
al
bent
et
al
infect
knockout
mice
ip
rout
model
sign
fever
leukopenia
thrombocytopenia
viremia
elev
liver
enzym
proinflammatori
cytokin
mice
moribund
succumb
diseas
day
postexposur
second
model
develop
use
interferon
alphabeta
receptor
knockout
mice
ifnar
bereczki
et
al
similar
observ
made
model
knockout
mous
model
anim
moribund
die
day
exposur
high
viremia
level
liver
spleen
character
studi
ifnar
mice
challeng
differ
rout
ip
im
subq
show
cchfv
caus
acut
diseas
high
viral
load
patholog
liver
lymphoid
tissu
increas
proinflammatori
respons
sever
thrombocytopenia
coagulopathi
death
characterist
human
diseas
proinflammatori
cytokin
chemokin
gcsf
increas
dramat
day
postchalleng
gmcsf
concentr
extrem
elev
time
deatheuthanasia
model
also
util
test
therapeut
ribavirin
arbidol
favipiravir
success
oestereich
et
al
experiment
vaccin
develop
cchf
evalu
model
provid
protect
compar
unvaccin
mice
buttigieg
et
al
canakoglu
et
al
p
thu
ifnar
mous
model
would
good
choic
test
medic
countermeasur
cchfv
although
impair
ifn
immun
respons
phenotyp
laboratori
anim
includ
nhp
show
littl
sign
infect
diseas
infect
cchfv
nalca
whitehous
butenko
et
al
util
agm
cercopithecu
aethiop
experiment
cchfv
infect
except
one
monkey
fever
day
postinfect
anim
show
sign
diseas
antibodi
viru
detect
three
five
monkey
includ
one
fever
fagbami
et
al
infect
two
pata
monkey
erythrocebu
pata
one
guinea
baboon
papio
papio
cchfv
wherea
three
anim
lowlevel
viremia
day
inocul
baboon
serum
neutral
antibodi
activ
day
postinfect
similar
result
obtain
hors
donkey
use
experiment
cchfv
infect
donkey
develop
lowlevel
viremia
rabinovich
et
al
hors
develop
littl
viremia
high
level
virusneutr
antibodi
remain
stabl
least
month
studi
suggest
hors
may
use
laboratori
obtain
serum
diagnost
possibl
therapeut
purpos
blagoveshchenskaya
et
al
blagoveshchenskaya
et
al
shepherd
et
al
infect
speci
small
african
wild
mammal
laboratori
rabbit
guinea
pig
syrian
hamster
cchfv
wherea
scrub
hare
lepu
saxatili
cape
ground
squirrel
xeru
inauri
red
veld
rat
aethomi
chrysophilu
whitetail
rat
mystromi
pumilio
guinea
pig
viremia
south
african
hedgehog
atelerix
frontali
highveld
gerbil
gerbilliscu
brantsii
namaqua
gerbil
desmodillu
auriculari
two
speci
multimamm
mous
mastomi
natalensi
mastomi
coucha
syrian
hamster
neg
viru
speci
regardless
viremia
level
develop
antibodi
respons
cchfv
iv
intracrani
infect
anim
show
onset
viremia
earlier
infect
subq
ip
rout
genu
hantaviru
uniqu
among
famili
bunyavirida
transmit
arthropod
vector
rather
rodent
schmaljohn
nichol
rodent
famili
murida
primari
reservoir
hantavirus
infect
host
anim
develop
persist
infect
typic
asymptomat
transmiss
achiev
inhal
infect
rodent
saliva
fece
urin
xu
et
al
human
infect
normal
trace
rural
set
activ
farm
land
develop
hunt
camp
possibl
site
transmiss
rodent
control
primari
rout
prevent
lednicki
virus
tropism
endotheli
cell
within
microvasculatur
lung
zaki
et
al
two
distinct
clinic
diseas
infect
yield
hemorrhag
fever
renal
syndrom
hfr
due
infect
old
world
hantavirus
hantaviru
pulmonari
syndrom
hp
caus
new
world
hantavirus
nichol
hfr
mainli
seen
outsid
america
associ
hantavirus
dobravabelgrad
also
known
dobrava
hantaan
puumala
seoul
lednicki
incub
last
week
present
flulik
initi
stage
develop
hemorrhag
manifest
ultim
renal
failur
thrombocytopenia
subsequ
develop
progress
shock
approxim
patient
overal
mortal
rate
infect
dobrava
hantaan
virus
typic
link
develop
sever
diseas
hp
first
diagnos
within
southwestern
unit
state
healthi
young
adult
becam
suddenli
ill
progress
sever
respiratori
distress
shock
etiolog
agent
respons
outbreak
identifi
sin
nombr
viru
snv
center
diseas
control
prevent
viru
still
lead
caus
within
north
america
hp
hp
due
hantavirus
report
argentina
bolivia
brazil
canada
chile
french
guiana
panama
paraguay
uruguay
padula
et
al
stephen
et
al
first
report
hp
main
recent
document
center
diseas
control
prevent
and
viru
andv
first
identifi
outbreak
chile
argentina
hantaviru
distinct
transmit
human
well
et
al
fulmin
diseas
lethal
observ
hfr
mortal
rate
four
phase
diseas
includ
prodrom
pulmonari
cardiac
depress
hematolog
manifest
peter
khan
incub
typic
occur
day
follow
exposur
young
et
al
unlik
hfr
renal
failur
major
contribut
factor
diseas
short
prodrom
phase
give
way
cardiopulmonari
involv
accompani
cough
gastrointestin
symptom
point
individu
typic
admit
hospit
pulmonari
function
hinder
continu
suffer
within
h
cardiopulmonari
involv
interstiti
edema
airspac
diseas
normal
follow
fatal
case
cardiogen
shock
note
hallin
et
al
syrian
golden
hamster
wide
util
small
anim
model
hantaviru
infect
hamster
inocul
im
passag
and
viral
strain
die
within
day
postinfect
clinic
sign
appear
h
prior
death
point
hamster
moribund
respiratori
distress
mortal
dose
depend
high
inoculum
lead
shorter
incub
death
studi
hamster
inocul
passag
snv
isol
hamster
develop
symptom
cours
observ
howev
antibodi
respons
viru
dose
depend
determin
via
elisa
hamster
infect
andv
signific
histopatholog
chang
lung
liver
spleen
interstiti
pneumonia
intraalveolar
edema
infecti
viru
could
recov
organ
viremia
began
day
last
day
postinfect
infect
hamster
andv
yield
similar
clinic
diseas
progress
seen
human
hp
includ
rapid
progress
death
fluid
pleural
caviti
signific
histopatholog
chang
lung
spleen
major
deviat
hamster
model
detect
infecti
viru
within
liver
normal
snv
caus
diseas
hamster
wahljensen
et
al
recent
studi
show
immunosuppress
dexamethason
cyclophosphamid
combin
caus
lethal
diseas
snv
hamster
brocato
et
al
diseas
similar
diseas
caus
andv
hamster
lethal
diseas
induc
newborn
mice
recapitul
clinic
symptom
observ
human
diseas
kim
mckee
diseas
outcom
much
depend
age
mice
younger
mice
much
suscept
viru
adult
mice
adult
mice
expos
hanta
viru
lead
fatal
diseas
depend
upon
viral
strain
rout
infect
diseas
progress
mark
neurolog
pulmonari
manifest
mirror
human
diseas
seto
et
al
wichmann
et
al
knockout
mice
lack
highli
suscept
hanta
viru
infect
muller
et
al
studi
panel
laboratori
strain
mice
mice
suscept
passag
hanta
viral
strain
inject
ip
anim
progress
neurolog
manifest
includ
paralys
convuls
succumb
infect
within
h
postinfect
clinic
diseas
markedli
differ
observ
human
case
wichmann
et
al
recent
studi
icr
mice
expos
htnv
strain
via
subq
rout
seto
et
al
mice
start
show
sign
diseas
day
postinocul
piloerect
trembl
hunch
loss
bodi
weight
labor
breath
sever
respiratori
diseas
observ
mice
studi
develop
nhp
model
success
recent
nhp
challeng
new
world
hantavirus
howev
clinic
sign
report
hooper
et
al
mcelroy
et
al
cynomolgu
monkey
challeng
clinic
isol
puumala
viru
develop
mild
diseas
klingstrom
et
al
sironen
et
al
challeng
andv
cynomolgu
macaqu
iv
aerosol
exposur
led
sign
diseas
anim
display
drop
total
lymphocyt
within
day
postinfect
four
six
aerosol
expos
monkey
iv
inject
monkey
develop
viremia
infecti
viru
could
isol
anim
recent
studi
rhesu
macaqu
inocul
intramuscular
rout
snv
passag
deer
mice
safronetz
et
al
characterist
hp
diseas
includ
rapid
onset
respiratori
distress
sever
pulmonari
edema
thrombocytopenia
leukocytosi
observ
promis
model
viremia
observ
day
prior
respiratori
sign
diseas
observ
day
postinocul
aspect
anim
model
would
use
test
medic
countermeasur
hanta
viru
famili
arenavirida
compos
two
serogroup
old
world
arenavirus
includ
lassa
fever
viru
lymphocyt
choriomening
viru
new
world
virus
pichind
viru
junin
viru
virus
share
common
clinic
manifest
mccormick
fisherhoch
lassa
fever
viru
endem
part
west
africa
outbreak
typic
seen
dri
season
januari
april
curti
viru
respons
infect
per
year
lead
approxim
death
khan
et
al
outbreak
report
guinea
sierra
leon
liberia
nigeria
central
african
republ
howev
case
sprung
germani
netherland
unit
kingdom
unit
state
due
transmiss
travel
commerci
airlin
amorosa
et
al
transmiss
viru
typic
occur
via
rodent
particular
multimamm
rat
mastomi
speci
complex
curti
human
becom
infect
inhal
aerosol
viru
eat
contamin
food
also
note
humantohuman
transmiss
direct
contact
infect
secret
needlestick
injuri
major
infect
asymptomat
howev
sever
diseas
occur
individu
incub
period
day
initi
onset
character
flulik
ill
follow
diarrheal
diseas
progress
hemorrhag
symptom
includ
encephalopathi
enceph
mening
third
patient
develop
deaf
earli
phase
diseas
perman
third
affect
overal
fatal
howev
admit
hospit
approv
vaccin
besid
support
measur
ribavirin
effect
start
within
day
mccormick
et
al
b
primari
anim
model
use
studi
lassa
fever
rhesu
macaqu
jahrl
et
al
aerosol
infect
lymphocyt
choriomening
viru
use
model
lassa
fever
rhesu
cynomolgu
monkey
expos
viru
develop
diseas
rhesu
mirror
close
diseas
cours
histopatholog
observ
human
infect
dane
et
al
iv
intragastr
inocul
viru
led
sever
dehydr
erythemat
skin
submucos
edema
necrot
foci
buccal
caviti
respiratori
distress
liver
sever
affect
viru
depict
measur
liver
enzym
ast
alt
lukashevich
et
al
diseas
dose
depend
iv
intramuscular
subq
inocul
requir
least
amount
viru
induc
diseas
aerosol
infect
eat
contamin
food
could
also
util
mimic
natur
rout
infect
peter
et
al
within
model
nhp
becom
virem
day
clinic
manifest
present
day
death
typic
occur
within
day
lukashevich
et
al
roda
et
al
intramuscular
inject
lassa
viru
cynomolgu
monkey
also
produc
neurolog
diseas
due
lesion
within
cn
hensley
et
al
pathogen
seen
select
case
human
lassa
fever
cummin
et
al
gunther
et
al
marmoset
model
recent
defin
util
subq
inject
lassa
fever
viru
viru
initi
detect
day
viremia
achiev
day
liver
enzym
elev
enlarg
liver
note
upon
autopsi
gradual
reduct
platelet
interstiti
pneumon
diagnos
minor
anim
physiolog
sign
seen
fatal
human
case
carrion
et
al
mice
develop
fatal
neurolog
disord
upon
intracerebr
inocul
lassa
although
outcom
infect
depend
mhc
background
age
anim
inocul
rout
salvato
et
al
knockout
mice
inocul
ip
lethal
nonleth
lassa
viru
strain
develop
hear
loss
accompani
damag
inner
ear
hair
cell
auditori
nerv
yun
et
al
guinea
pig
inbr
strain
highli
suscept
lassa
viru
infect
outbr
hartley
strain
less
suscept
thu
strain
prefer
model
given
assur
lethal
clinic
manifest
mirror
seen
human
rhesu
jahrl
et
al
infect
pichind
viru
passag
guinea
pig
also
use
diseas
sign
includ
fever
weight
loss
vascular
collaps
eventu
death
lucia
et
al
qian
et
al
guinea
pig
excel
model
given
result
similar
diseas
pattern
viral
distribut
histopatholog
immun
respons
human
connolli
et
al
katz
starr
infect
hamster
cotton
rat
isol
pirit
viru
similar
character
human
nhp
guinea
pig
model
viru
inject
ip
result
lethargi
anorexia
within
day
viru
first
detect
day
reach
maximum
titer
within
day
neurolog
symptom
began
appear
time
anim
die
day
pneumon
pulmonari
hemorrhag
edema
also
present
sbrana
et
al
result
recapitul
nonadapt
pichind
viru
buchmeier
rawl
gowen
et
al
smee
et
al
lentivirus
subfamili
retrovirida
includ
human
immunodefici
viru
hiv
viru
infect
world
popul
greater
proport
infect
death
occur
subsaharan
africa
worldwid
approxim
million
death
per
year
children
transmiss
hiv
occur
exposur
infecti
bodi
fluid
two
speci
lower
infect
virul
confin
mostli
west
africa
vast
major
case
worldwid
de
cock
et
al
hiv
target
thelper
cell
macrophag
dendrit
cell
field
et
al
acut
infect
occur
week
exposur
flulik
symptom
viremia
follow
chronic
infect
symptom
acut
phase
may
includ
fever
bodi
ach
nausea
vomit
headach
lymphadenopathi
pharyng
rash
sore
mouth
esophagu
tcell
activ
kill
hivinfect
cell
respons
antibodi
product
seroconvers
acquir
immun
defici
syndrom
aid
develop
tcell
declin
less
thu
cellmedi
immun
becom
impair
person
suscept
opportunist
infect
well
certain
cancer
hiv
narrow
host
rang
like
viru
unabl
antagon
evad
effector
molecul
interferon
respons
thippeshappa
et
al
human
mice
creat
engraft
human
cell
tissu
scid
mice
critic
develop
mous
model
studi
hiv
infect
number
differ
human
mous
model
allow
studi
hiv
infect
context
intact
function
human
innat
adapt
immun
respons
berg
rowan
scidhu
hiv
infect
model
proven
use
particularli
screen
antivir
therapeut
denton
et
al
melku
et
al
number
differ
human
mous
model
develop
studi
hiv
includ
hnog
hnsg
nodscid
blt
hnsg
blt
karpel
et
al
li
et
al
shimizu
et
al
human
stem
cell
deriv
umbil
cord
blood
fetal
liver
use
human
baenzig
et
al
watanab
et
al
infect
ip
inject
success
littl
peripher
blood
engraft
berg
et
al
vagin
rectal
transmiss
model
develop
blt
scid
hu
mice
mice
harbor
human
bone
marrow
liver
thymu
tissu
viremia
occur
within
approxim
day
postinocul
mani
model
spleen
lymph
node
thymu
tissu
highli
posit
viru
similar
human
brainard
et
al
importantli
deplet
human
tcell
observ
blood
lymphoid
tissu
hivinfect
human
mice
least
mechan
pathogenesi
occur
hivinfect
human
also
occur
hivinfect
human
mous
model
baenzig
et
al
neff
et
al
advantag
model
mice
suscept
hiv
infect
thu
impact
drug
intend
viral
target
test
one
caveat
mice
common
mucos
immun
system
human
due
differ
distribut
addressin
holmgren
czerkinski
thu
murin
mucos
immun
respons
hiv
reflect
human
anoth
strategi
use
human
human
transgen
luciferas
report
mous
studi
pseudoviru
entri
gruell
et
al
transgen
tg
rat
also
use
studi
hiv
relat
patholog
immunopathogenesi
neuropatholog
lentz
et
al
reid
et
al
clinic
sign
includ
skin
lesion
wast
respiratori
difficulti
neurolog
sign
brain
volum
decreas
document
tg
rat
thu
use
model
neuropatholog
particular
number
import
nhp
model
human
hiv
infect
hessel
haigwood
adapt
obtain
four
passag
pigtail
macaqu
transient
deplet
cell
acut
infect
hatziioann
et
al
result
diseas
sever
similar
aid
human
deplet
tcell
kimata
simian
immunodefici
viru
siv
infect
macaqu
wide
use
platform
model
hiv
infect
human
demberg
robertguroff
walker
et
al
importantli
nhp
similar
pharmacokinet
metabol
mucos
tcell
home
receptor
vascular
addressin
human
thu
correl
protect
hiv
still
complet
known
immun
respons
hiv
infect
vaccin
like
compar
model
mimic
infect
use
contamin
needl
iv
sexual
transmiss
vagin
rectal
matern
transmiss
utero
breast
milk
keel
et
al
miller
et
al
stone
et
al
also
macaqu
model
studi
emerg
clinic
implic
hiv
drug
resist
van
rompay
et
al
model
routin
util
rhesu
macaqu
macaca
mulatta
cynomolgu
macaqu
fasiculari
pigtail
macaqu
macaca
nemestrina
age
use
depend
need
studi
instanc
use
newborn
macaqu
may
practic
evalu
effect
prolong
drug
therapi
diseas
progress
howev
adult
nhp
frequent
employ
femal
pigtail
macaqu
use
investig
effect
menstrual
cycl
hiv
suscept
vishwanathan
et
al
studi
perform
anim
laboratori
nhp
must
simian
type
retroviru
free
siv
seroneg
siv
infect
pigtail
macaqu
use
model
hiv
peripher
nervou
system
patholog
wherein
axotomi
perform
regener
axon
studi
ebenez
et
al
exposur
model
system
typic
singl
highdos
challeng
iv
infect
rhesu
macaqu
tcid
highli
pathogen
siv
induc
aid
macaqu
within
month
mean
month
fuller
et
al
peak
viremia
occur
around
week
aid
model
often
defin
tcell
drop
less
baselin
valu
altern
repeat
low
dose
challeng
often
util
depend
requir
model
hen
et
al
moldt
et
al
reynold
et
al
sinc
nhp
infect
hiv
develop
infect
clinic
diseas
cours
similar
human
siv
laboratoryengin
chimer
virus
shiv
use
surrog
nhp
infect
pathogen
siv
may
develop
clinic
diseas
progress
aid
thu
use
pathogenesi
model
disadvantag
siv
ident
close
relat
howev
polymeras
region
siv
homolog
suscept
mani
revers
transcriptas
rt
proteas
inhibitor
siv
gener
suscept
nonnucleosid
inhibitor
thu
rt
usual
put
siv
studi
uberla
et
al
similar
hiv
polymeras
region
therefor
suscept
nucleosid
rt
integras
inhibit
witvrouw
et
al
nhp
infect
asymptomat
period
diseas
progress
resembl
aid
human
character
weight
losswast
tcell
deplet
addit
util
chemokin
receptor
coreceptor
similar
hiv
import
drug
target
entri
veazey
et
al
nhp
infect
shiv
strain
may
develop
aid
model
use
test
vaccin
efficaci
exampl
rtshiv
envshiv
use
test
evalu
drug
may
target
envelop
rt
respect
uberla
et
al
one
disadvantag
highli
virul
envshiv
p
use
coreceptor
note
envshiv
use
coreceptor
less
virul
viremia
develop
resolv
without
diseas
progress
humbert
et
al
simiantrop
st
contain
vif
gene
siv
infect
pigtail
macaqu
viru
result
viremia
detect
month
follow
clearanc
haigwood
number
rout
util
siv
shiv
infect
nhp
iv
inocul
common
rout
mucos
rout
includ
vagin
rectal
intracolon
mucos
rout
requir
higher
onetim
dose
iv
rout
infect
vagin
rout
femal
macaqu
treat
depoprovera
estrogen
month
infect
synchron
menstrual
cycl
thin
epitheli
line
vagina
increas
suscept
infect
atraumat
vagin
instil
burton
et
al
upon
vagin
instil
tcid
peak
viremia
seen
around
day
postexposur
greater
copiesml
drop
thereaft
constant
level
rna
copiesml
day
beyond
anoth
exampl
investig
effect
vaccin
plu
vagin
microbicid
prevent
infect
rhesu
macaqu
vagin
infect
high
dose
barouch
et
al
exampl
intrarect
model
util
juvenil
pigtail
macaqu
challeng
intrarect
tcid
siv
studi
pathogenesi
relat
virul
factor
vpx
belshan
et
al
viremia
peak
approxim
day
copiesml
viral
rna
express
cell
mesenter
lymph
node
male
genit
tract
seen
viral
sanctuari
persist
high
level
hiv
shed
even
antiretrovir
therapi
better
understand
effect
haart
therapi
viru
tcell
male
genit
tract
adult
male
cynomolgu
macaqu
intraven
inocul
male
genit
tract
tissu
test
euthanasia
pcr
ihc
situ
hybrid
moreau
et
al
pediatr
model
develop
infant
rhesu
macaqu
infect
siv
allow
studi
impact
development
immunolog
differ
diseas
cours
abel
importantli
mothertoinf
transmiss
model
also
develop
jayaraman
et
al
pregnant
femal
pigtail
macaqu
infect
second
trimest
mid
iv
rout
four
nine
infant
infect
one
utero
three
either
intrapartum
immedi
postpartum
nurs
model
use
studi
factor
involv
transmiss
well
underli
immunolog
nhp
infect
siv
shiv
routin
evalu
weight
loss
activ
level
stool
consist
appetit
viru
level
blood
tcell
popul
cytokin
chemokin
level
antibodi
respons
cytotox
tlymphocyt
respons
may
also
evalu
ultim
goal
hiv
vaccin
steril
immun
prevent
infect
howev
realist
result
may
reduc
sever
infect
perman
prevent
progress
strategi
includ
live
attenu
nonrepl
subunit
vaccin
variabl
efficaci
nhp
due
genet
host
mhc
trim
allel
differ
challeng
strain
challeng
rout
letvin
et
al
nhp
model
led
develop
antivir
treatment
effect
reduc
viral
load
inde
transmiss
hiv
among
human
one
prefer
variat
model
test
longterm
clinic
consequ
antivir
treatment
use
newborn
macaqu
treat
birth
onward
case
decad
van
rompay
et
al
unfortun
howev
success
nhp
studi
alway
translat
success
human
seen
recent
step
studi
use
adenovirusbas
vaccin
approach
buchbind
et
al
vaccin
human
protect
may
even
suscept
hiv
viremia
reduc
infect
attenu
hope
regard
challeng
rout
iv
exposur
difficult
protect
mucos
exposur
use
worst
case
scenario
howev
efficaci
one
mucos
rout
usual
compar
mucos
rout
human
anim
papillomavirus
caus
benign
epitheli
prolifer
wart
malign
tumor
variou
tissu
infect
bosch
de
sanjos
human
papillomavirus
differ
strain
caus
wart
skin
oropharynx
nasopharynx
larynx
anogenit
tissu
approxim
one
third
papillomavirus
transmit
sexual
virul
subtyp
place
individu
high
risk
cervic
cancer
head
neck
cancer
caus
particularli
oropharyng
cancer
major
challeng
studi
virus
papillomavirus
gener
infect
speci
outsid
natur
host
caus
larg
spectrum
sever
thu
wildtyp
anim
model
identifi
suscept
hpv
howev
number
use
surrog
model
exist
use
anim
papillomavirus
natur
host
close
relat
speci
borzacchiello
et
al
brandsma
campo
model
facilit
recent
develop
use
highli
effect
prophylact
hpv
vaccin
rabenau
et
al
wildtyp
inbr
mice
use
studi
diseas
caus
papillomavirus
unless
engraft
relev
tissu
orthotop
transplant
transgen
often
use
look
immunogen
vaccin
jagu
et
al
oosterhui
et
al
transgen
mice
use
hpv
anim
model
typic
express
viral
oncogen
entir
earli
region
keratin
promot
activ
basal
cell
mous
epithelium
chow
cancer
model
develop
upon
extend
estrogen
exposur
maufort
et
al
ocadizdelgado
et
al
stelzer
et
al
thoma
et
al
transgen
mice
constitut
activ
wntbcatenin
signal
cervic
epitheli
cell
express
hpb
oncoprotein
develop
invas
cervic
squamou
carcinoma
bulut
uren
tumor
occur
within
month
approxim
time
anoth
model
use
mice
express
transgen
treat
topic
anthracen
dmba
de
azambuja
et
al
mice
develop
benign
malign
cutan
lesion
cervic
cancer
also
induc
human
cervic
cancer
xenograft
transplant
onto
flank
athym
mice
serial
transplant
thereaft
hiroshima
et
al
siola
hannon
wildtyp
immunocompet
rodent
model
use
coucha
natur
infect
mastomi
natalensi
papillomaviru
mnpv
vinzon
et
al
mnpv
induc
papilloma
keratoacanthoma
squamou
cell
carcinoma
provid
mean
studi
vaccin
immunocompet
small
anim
model
wild
cottontail
rabbit
sylvilagu
floridanu
natur
host
cottontail
rabbit
papillomaviru
crpv
viru
also
infect
domest
rabbit
oryctolagu
cuniculu
close
relat
speci
breitburd
et
al
model
papilloma
rang
cutan
squamou
cell
carcinoma
one
end
spectrum
spontan
regress
lesion
result
crpv
domest
rabbit
typic
contain
infecti
viru
canin
oral
papillomaviru
copv
caus
florid
warti
lesion
mucosa
oral
caviti
within
week
postexposur
experiment
set
johnston
et
al
mucosatroph
natur
virus
result
oropharyng
papilloma
morpholog
similar
human
vagin
papilloma
caus
make
use
model
nichol
et
al
lesion
typic
spontan
regress
week
appear
model
therefor
use
understand
interplay
host
immun
defens
viral
pathogenesi
male
femal
beagl
age
week
year
histori
copv
typic
use
studi
infect
achiev
applic
droplet
viru
extract
multipl
cm
scarifi
area
within
mucosa
upper
lip
anesthet
beagl
nichol
et
al
investig
rais
concern
dog
suitabl
model
highrisk
hpvinduc
oral
cancer
staff
bovin
papillomaviru
bpv
wider
host
rang
papillomavirus
infect
fibroblast
cell
numer
ungul
campo
infect
cattl
feed
bracken
fern
carcinogen
result
lesion
oral
esophag
mucosa
lack
detect
viral
dna
bpv
infect
cattl
result
rang
diseas
skin
wart
cancer
upper
gastrointestin
tract
urinari
bladder
papillomatosi
peni
teat
udder
final
rhesu
papillomaviru
rhpv
sexual
transmit
papillomavirus
rhesu
macaqu
cynomolgu
macaqu
similar
associ
develop
cervic
cancer
ostrow
et
al
wood
et
al
monkeypox
viru
mpxv
caus
diseas
anim
human
human
monkeypox
clinic
almost
ident
ordinari
smallpox
occur
mostli
rainforest
central
western
africa
viru
maintain
natur
rodent
reservoir
includ
k
viral
diseas
squirrel
charatan
khodakevich
et
al
mpxv
discov
poxlik
diseas
outbreak
among
laboratori
monkey
mostli
cynomolgu
rhesu
macaqu
denmark
human
case
observ
outbreak
first
human
case
recogn
distinct
diseas
zair
present
drc
continu
occurr
smallpoxlik
ill
despit
erad
effort
smallpox
area
global
erad
campaign
extens
vaccin
central
africa
decreas
incid
human
monkeypox
absenc
immun
gener
born
sinc
time
increas
depend
bush
meat
result
renew
emerg
diseas
summer
wellknown
outbreak
midwest
first
occurr
monkeypox
diseas
unit
state
western
hemispher
among
report
case
human
case
laboratori
confirm
outbreak
nalca
et
al
sejvar
et
al
determin
nativ
prairi
dog
cynomi
sp
hous
rodent
import
ghana
west
africa
primari
sourc
outbreak
viru
mainli
transmit
human
handl
infect
anim
direct
contact
infect
anim
bodi
fluid
lesion
persontoperson
spread
occur
larg
respiratori
droplet
direct
contact
fenner
clinic
featur
human
monkeypox
similar
ordinari
smallpox
breman
arita
period
diseas
begin
fever
malais
headach
sore
throat
cough
main
sign
diseas
distinguish
monkeypox
smallpox
swollen
lymph
node
lymphaden
observ
patient
develop
rash
di
giulio
eckburg
fenner
typic
maculopapular
rash
follow
prodrom
period
gener
last
day
averag
size
skin
lesion
cm
progress
lesion
follow
order
macul
papul
vesicl
pustul
umblic
scab
desquam
last
typic
week
fatal
rate
among
unvaccin
popul
death
gener
occur
week
diseas
fenner
nalca
et
al
mpxv
highli
pathogen
varieti
laboratori
anim
mani
anim
model
develop
use
differ
speci
differ
rout
exposur
tabl
due
unavail
variola
viru
smallpox
develop
anim
model
similar
diseas
manifest
human
similar
mpxv
one
pox
virus
util
heavili
develop
number
small
anim
model
via
differ
rout
exposur
wildderiv
inbr
mous
mous
icr
mous
prairi
dog
african
dormic
ground
squirrel
gambian
pouch
rat
highli
suscept
mpxv
differ
exposur
rout
americo
et
al
falendysz
et
al
hutson
et
al
osorio
et
al
sbrana
et
al
schultz
et
al
sergeev
et
al
stabenow
et
al
tesh
et
al
xiao
et
al
casteij
mice
one
inbr
mous
strain
test
suscept
mpxv
show
weight
loss
dose
depend
mortal
exposur
mpxv
studi
ip
rout
challeng
indic
higher
suscept
mpxv
compar
rout
americo
et
al
scidbalbc
mice
also
suscept
ip
challeng
rout
diseas
result
mortal
day
postinfect
osorio
et
al
similarli
mice
infect
mpxv
infect
result
weight
loss
mortal
day
postexposur
recent
sergeev
et
al
show
challeng
icr
mice
mpxv
result
purul
conjunct
blephar
ruffl
fur
mice
although
death
mous
model
mention
promis
screen
therapeut
poxvirus
test
addit
model
requir
advanc
develop
high
dose
mpxv
ip
rout
caus
mortal
day
postexposur
day
postexposur
respect
ground
squirrel
tesh
et
al
diseas
progress
quickli
anim
letharg
moribund
day
postexposur
without
pox
lesion
respiratori
chang
comparison
studi
usa
mpxv
central
african
strain
mpxv
strain
ground
squirrel
subq
rout
result
system
diseas
mortal
day
postexposur
diseas
resembl
hemorrhag
smallpox
noseble
impair
coagul
paramet
hemorrhag
lung
anim
anoth
studi
sergeev
et
al
show
challeng
mpxv
caus
fever
lymphaden
skin
rash
ground
squirrel
day
postexposur
mortal
observ
anim
day
postexposur
sergeev
et
al
sinc
mpxv
transmit
infect
prairi
dog
us
outbreak
anim
model
thoroughli
studi
util
test
therapeut
vaccin
compar
small
anim
model
hutson
et
al
keckler
et
al
smith
et
al
xiao
et
al
studi
use
ip
id
rout
exposur
show
mpxv
highli
infecti
prairi
dog
ip
infect
west
african
mpxv
strain
caus
sever
diseas
mortal
challeng
rout
anorexia
lethargi
common
sign
diseas
exposur
rout
contrast
ip
rout
rout
exposur
caus
sever
pulmonari
edema
necrosi
lung
prairi
dog
splenic
necrosi
hepat
lesion
observ
ipinfect
anim
xiao
et
al
hutson
et
al
african
congo
basin
strain
show
strain
rout
caus
smallpoxlik
diseas
longer
incub
period
importantli
gener
pox
lesion
therefor
model
util
test
therapeut
vaccin
pox
virus
furthermor
mpxv
challeng
prairi
dog
use
perform
vivo
bioluminesc
imag
bli
studi
falendysz
et
al
bli
studi
show
real
time
spread
viru
prairi
dog
well
potenti
rout
shed
transmiss
african
dormous
suscept
mpxv
footpad
inject
rout
schultz
et
al
mice
decreas
activ
hunch
postur
dehydr
conjunct
weight
loss
viral
dose
pfu
provid
mortal
mean
time
death
day
upper
gastrointestin
hemorrhag
hepatomegali
lymphadenopathi
lung
hemorrhag
observ
necropsi
hemorrhag
sever
organ
model
resembl
hemorrhag
smallpox
recent
studi
comparison
diseas
pathogenesi
perform
use
live
bioluminesc
imag
casteij
mous
african
dormous
challeng
low
dose
mpxv
earl
et
al
follow
challeng
mpxv
dissemin
occur
blood
lymphat
system
dormic
compar
dissemin
nasal
caviti
lung
casteij
mice
diseas
cours
much
faster
casteij
mice
earl
et
al
consid
limit
avail
prairi
dog
ground
squirrel
african
dormic
lack
reagent
specif
speci
commerci
sourc
speci
small
anim
model
attract
character
vaccin
countermeasur
test
studi
nhp
expos
mpxv
sever
differ
rout
develop
anim
model
mpxv
edghillsmith
et
al
johnson
et
al
nalca
et
al
stittelaar
et
al
zaucha
et
al
studi
use
aerosol
rout
exposur
observ
macaqu
mild
anorexia
depress
fever
lymphadenopathi
day
postexposur
nalca
et
al
complet
blood
count
clinic
chemistri
show
abnorm
similar
human
monkeypox
case
leukocytosi
thrombocytopenia
huhn
et
al
whole
blood
throat
swab
viral
load
peak
around
day
survivor
gradual
decreas
day
postexposur
sinc
dose
pfu
pfu
pfu
result
lethal
anim
wherea
dose
pfu
result
lethal
surviv
dose
depend
main
pitfal
model
lack
pox
lesion
high
dose
anim
succumb
diseas
develop
pox
lesion
low
challeng
dose
pox
lesion
observ
comparison
iv
model
recent
studi
also
evalu
cytokin
level
aerosol
challeng
anim
tree
et
al
tree
et
al
show
increas
dramat
day
postexposur
day
death
like
occur
viral
dna
detect
tissu
result
support
idea
cytokin
storm
caus
mortal
monkeypox
diseas
mpxv
caus
dose
depend
diseas
nhp
given
iv
rout
johnson
et
al
studi
show
pfu
iv
challeng
result
system
diseas
fever
lymphadenopathi
maculapapular
rash
mortal
infect
model
skip
upper
respiratori
system
deposit
viru
trachea
deliv
viru
directli
airway
without
regard
particl
size
physiolog
deposit
occur
process
inhal
fibrinonecrot
bronchopneumonia
describ
anim
receiv
pfu
mpxv
intratrach
stittelaar
et
al
although
similar
challeng
dose
mpxv
infect
result
similar
viremia
nhp
aerosol
rout
infect
time
first
peak
delay
day
intratrach
expos
macaqu
compar
aerosol
infect
amount
viru
detect
qpcr
approxim
lower
suggest
local
replic
promin
aerosol
deliveri
compar
rout
intrabronchi
rout
exposur
result
pneumonia
nhp
johnson
et
al
delay
onset
clinic
sign
viremia
observ
diseas
progress
model
similar
aerosol
infect
model
number
pox
lesion
much
less
iv
infect
model
major
downsid
iv
intrabronchi
model
initi
infect
respiratori
tissu
incub
prodrom
phase
circumv
direct
inocul
viru
blood
stream
lung
import
limit
util
model
test
possibl
vaccin
treatment
efficaci
may
depend
protect
respiratori
mucosa
target
subsequ
earli
stage
infect
repres
challeng
model
although
aerosol
model
natur
rout
transmiss
human
varv
infect
secondari
rout
human
mpxv
infect
lack
pox
lesion
main
drawback
model
therefor
model
use
test
medic
countermeasur
endpoint
biomark
initi
treatment
chosen
care
hepat
b
viru
hbv
one
common
infect
worldwid
million
peopl
chronic
infect
case
per
year
liver
cancer
due
infect
lee
viru
natur
infect
human
chimpanze
guha
et
al
hbv
transmit
parenter
postnat
infect
mother
also
transmit
sexual
contact
iv
drug
use
blood
transfus
acupunctur
lai
et
al
age
one
infect
dictat
risk
develop
chronic
diseas
hyam
acut
infect
adulthood
selflimit
result
flulik
symptom
progress
hepatocellular
involv
observ
develop
jaundic
clinic
symptom
hbv
infect
last
week
resolv
ganem
princ
acut
phase
lifetim
immun
achiev
wright
lau
infect
less
develop
chronic
form
diseas
chronic
seriou
outcom
diseas
result
cirrhosi
liver
cancer
hepatocellular
carcinoma
time
like
develop
chronic
infect
individu
noncarri
beasley
viral
determin
cellular
transform
yet
determin
although
studi
involv
woodchuck
hepat
viru
suggest
x
protein
may
respons
spandau
lee
mani
individu
asymptomat
complic
emerg
relat
chronic
hbv
carriag
chimpanze
uniqu
strain
circul
within
popul
hu
et
al
found
wildcaught
anim
africa
posit
hbv
antigen
lander
et
al
natur
experiment
challeng
viru
follow
cours
human
diseas
howev
acut
model
diseas
princ
date
chimpanze
reliabl
method
ensur
plasma
vaccin
free
infecti
particl
princ
brotman
anim
model
use
studi
new
therapeut
vaccin
chimpanze
especi
ideal
studi
given
immun
respons
infect
directli
mirror
human
nayersina
et
al
recent
regul
nation
institut
health
nih
restrict
use
great
ape
anim
model
forc
research
find
altern
model
hbv
infect
nhp
evalu
gibbon
orangutan
rhesu
monkey
although
anim
infect
hbv
none
develop
hepat
lesion
liver
damag
note
monitor
liver
enzym
pillot
mice
permiss
infect
thu
numer
transgen
human
line
express
hbv
protein
creat
facilit
usag
anim
model
includ
immunocompet
immunosuppress
host
caveat
mous
line
reproduc
acut
form
diseas
guha
et
al
recent
entir
genom
hbv
transfer
immunocompet
mous
line
via
adenoviru
provid
model
persist
infect
huang
et
al
anoth
model
develop
hydrodynam
inject
hbv
genom
liver
mice
liu
et
al
yang
et
al
although
model
stress
mice
liver
toxic
success
use
evalu
antivir
hbv
mccaffrey
et
al
liver
chimer
mous
model
addit
set
surrog
model
hbv
infect
dandri
lutgehetmann
model
human
hepatocyt
integr
murin
liver
parenchyma
allweiss
dandri
model
might
use
test
antivir
well
studi
molecular
biolog
hbv
infect
hbv
also
studi
use
surrog
virus
natur
occur
mammalian
hepadna
virus
mason
et
al
woodchuck
hepat
viru
induc
hepatocellular
carcinoma
summer
et
al
within
popul
neonat
woodchuck
suscept
chronic
infect
cote
et
al
major
differ
two
hepat
isol
rate
induc
cancer
almost
chronic
carrier
develop
hepatocellular
carcinoma
within
year
initi
infect
woodchuck
wherea
human
carcinogenesi
take
much
longer
gerin
et
al
acut
infect
strongli
resembl
occur
cours
human
diseas
selflimit
acut
phase
result
transient
viremia
potenti
chronic
carriag
tennant
challeng
viru
neonat
lead
chronic
infect
adult
develop
acut
phase
diseas
buendia
close
relat
speci
woodchuck
marmota
himalayan
anim
also
suscept
woodchuck
hepadna
viru
upon
iv
inject
marmot
himalayan
develop
acut
hepat
product
infect
lucifora
et
al
hepat
viru
hdv
depend
upon
hbv
undergo
replic
success
infect
human
host
gerin
two
mode
infect
possibl
virus
coinfect
person
simultan
infect
superinfect
chronic
carrier
hbv
subsequ
infect
hdv
purcel
et
al
coinfect
lead
similar
diseas
seen
hbv
alon
howev
superinfect
result
chronic
hdv
infect
sever
liver
damag
guilhot
et
al
coinfect
superinfect
demonstr
within
chimpanze
woodchuck
inocul
human
hepat
ponzetto
et
al
recent
publish
report
demonstr
use
human
chimer
upa
mous
studi
interact
two
virus
drug
test
lutgehetmann
et
al
new
model
rang
nhp
small
anim
repres
diseas
characterist
human
necessari
studi
viral
host
factor
drive
diseas
pathogenesi
evalu
medic
countermeasur
ideal
anim
model
human
viral
diseas
close
recapitul
spectrum
clinic
symptom
pathogenesi
observ
cours
human
infect
whenev
feasibl
model
use
viru
strain
infect
human
also
prefer
viru
low
passag
clinic
isol
thu
anim
passag
adapt
avoid
model
speci
identifi
suscept
ideal
experiment
rout
infect
would
mirror
occur
natur
diseas
order
understand
interplay
contribut
immun
system
infect
immunocompet
anim
use
aforement
characterist
alway
satisfi
howev
often
viru
must
adapt
knockout
mice
must
use
andor
diseas
perfectli
mimick
anim
model
wellcharacter
anim
model
critic
licensur
satisfi
fda
anim
rule
rule
appli
situat
vaccin
therapeut
efficaci
safe
ethic
test
human
thu
licensur
come
preclin
test
perform
anim
model
mani
field
virolog
move
toward
standard
model
use
across
institut
test
vaccin
therapeut
current
exampl
effort
within
filoviru
commun
anim
model
euthanasia
criteria
assay
viru
strain
process
standard
hope
effort
enabl
result
efficaci
test
medic
countermeasur
compar
across
institut
chapter
summar
best
model
avail
virus
describ
